Peter FalkaiPsychiater und Neurowissenschaftler

Publikationen

Alle Arbeiten seit 1986

Die vollständige Liste der Arbeiten, die PubMed unter seinem Namen führt. Jeder Titel führt zum Volltext, die PMID zu PubMed.

1.009Einträge in PubMed
34.292Zitationen laut NIH iCite
93h-Index auf Basis dieser Zitationen
205Fachzeitschriften

Pro Jahr

Seit 2020 erscheinen im Schnitt rund 60 Arbeiten pro Jahr, viele davon aus großen Verbünden. 2026 ist bis Mitte Oktober erfasst.

0204060801986199620022006201220241986: 119861987: 01988: 21989: 21990: 219901991: 11992: 31993: 11994: 31995: 419951996: 51997: 51998: 91999: 152000: 820002001: 62002: 72003: 162004: 142005: 1720052006: 202007: 122008: 332009: 352010: 4020102011: 332012: 372013: 472014: 412015: 4120152016: 432017: 302018: 412019: 332020: 5020202021: 562022: 602023: 712024: 492025: 6620252026: 50
Erst- oder AlleinautorLetztautorKoautor

2026

  1. The role of white matter microstructure in the association between childhood maltreatment and adult post-traumatic symptoms.Berger L et al. Mol Psychiatry 2026. PMID 42859210
  2. Using multi-trait polygenic scores to predict lithium responsiveness in patients with bipolar disorder.Sharew NT et al. Br J Psychiatry 2026. PMID 42841250
  3. Machine-learning classification of documented pedophilic sexual interest from eye-tracking patterns.Popovic D et al. Res Sq 2026. Preprint PMID 42856482
  4. The global cost of schizophrenia: a health economic modelling study.LetztautorWelter LS et al. Int J Ment Health Syst 2026. PMID 42823740
  5. Associations between community contextual factors and depressive symptoms: postcode-based data linkage of POKAL survey data with publicly available German routine data.Schoenweger P et al. Eur Arch Psychiatry Clin Neurosci 2026. PMID 42814112
  6. Senescence-associated secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data.Seitz-Holland J et al. Brain Behav Immun 2026. PMID 42764136
  7. Psychometric validation of research domain criteria, general health, and clinical-psychosocial parts of the minimum dataset of the German Center for Mental Health-informing a Delphi process.Förstner BR et al. Eur Arch Psychiatry Clin Neurosci 2026. PMID 42631718
  8. Disentangling white matter correlates of symptom severity and general impairment in early psychosis.Penzel N et al. Mol Psychiatry 2026. PMID 42618605
  9. Modulation of neuronal excitability and plasticity by BHLHE41 conveys lithium non-responsiveness.Stephan M et al. Mol Psychiatry 2026. PMID 42613416
  10. The World Psychiatric Association (WPA) Guideline on Schizophrenia Spectrum Disorders Management for Low- and Middle-Income Countries.LetztautorCastaldelli-Maia JM et al. Int J Soc Psychiatry 2026. PMID 42565595
  11. Investigating changes in the blood-brain barrier in schizophrenia spectrum disorders: design and methodology of a longitudinal dynamic contrast-enhanced MRI study.Wendl A et al. Eur Arch Psychiatry Clin Neurosci 2026. PMID 42550194
  12. Individual factors associated with physical activity adherence in schizophrenia: an exploratory secondary analysis of two randomized controlled trials.Kuprat S et al. Front Psychol 2026. PMID 42582200
  13. Mice lacking two alleles of the schizophrenia risk geneanddisplay deficits in anxiety-related behavior, sensorimotor gating, and cognition.Chang MH et al. Front Cell Neurosci 2026. PMID 42453294
  14. Effects of quetiapine on cognitive functioning in schizophrenia: evidence for the remyelination hypothesis?LetztautorIsing M et al. Eur Arch Psychiatry Clin Neurosci 2026. PMID 42400655
  15. Lifetime and acute risk of suicidality by profiles of early life adversity: an observational cohort study in a high-risk population.Wolf J et al. Sci Rep 2026. PMID 42386898
  16. Knowledge About Psychosocial Interventions Among Individuals With Severe Mental Illness: Results of a Cross-Sectional Study.Stein SN et al. Community Ment Health J 2026. PMID 42384141
  17. Cognitive effects of transcranial random noise stimulation in schizophrenia: A triple-blind randomized placebo-controlled pilot study.Körber K et al. J Psychiatr Res 2026. PMID 42365849
  18. Two decades of progress in schizophrenia: Evolution, current insights, and future directions.Alvarez-Jimenez M et al. Span J Psychiatry Ment Health 2026. PMID 42341880
  19. Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.LetztautorHasan A et al. Commun Med (Lond) 2026. PMID 42303794
  20. Childhood maltreatment is linked to transdiagnostic age- and sex-specific cortical thinning and reduced amygdalar volume in young adults.Huth F et al. Eur Neuropsychopharmacol 2026. PMID 42263356
  21. Frequency and Correlates of Inaccurate Psychiatric Diagnoses in 401 Adults Hospitalized for Major Depressive Disorder: A Comparison of Clinical vs. Research Interview-Based Diagnoses.Nöhles VB et al. CNS Spectr 2026. PMID 42260735
  22. Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI Canada.Solmi M et al. World J Biol Psychiatry 2026. PMID 422017551 Zitationen
  23. Evaluation of a transdiagnostic mental health intervention in German primary care: a parallel-group, two-arm, cluster randomised controlled pilot study.Ebert C et al. BMC Prim Care 2026. PMID 421688921 Zitationen
  24. Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D study.Fritze S et al. Eur Neuropsychopharmacol 2026. PMID 42155212
  25. Comparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical procedures: systematic review and meta-analysis.Vilela-Filho O et al. J Neurol Neurosurg Psychiatry 2026. PMID 419465551 Zitationen
  26. The patterns of relapse and abstinence: using machine learning to identify a multidimensional signature of long-term outcome after inpatient alcohol withdrawal treatment.Raabe FJ et al. Front Psychiatry 2026. PMID 42079306
  27. Concurrent (Dual) Disorder Management Guidelines: Systematic Review Update.Hakobyan S et al. J Clin Med 2026. PMID 42074929
  28. Seasonal longitudinal effects of winter birth on psychopathology, cognition, and functioning in schizophrenia-spectrum and affective disorders: Findings from the PsyCourse Study.Pérez-Ramos A et al. J Affect Disord 2026. PMID 420342521 Zitationen
  29. Investigating the association of a selected inflammatory protein panel with suicide attempts in the PsyCourse Study: A pilot study.Oraki Kohshour M et al. Psychoneuroendocrinology 2026. PMID 42030691
  30. Baseline characteristics of a diagnostically defined early psychosis cohort entering supported employment and education: findings from the SEEearly trial.Willert A et al. Eur Arch Psychiatry Clin Neurosci 2026. PMID 41968170
  31. Epigenetic Aging and Cognitive Performance in General and Psychiatric Populations: A Systematic Review and Narrative Synthesis.Yusupov N et al. Biol Psychiatry Glob Open Sci 2026. PMID 42318041
  32. Neurobiological Signatures of Trauma, Personality, and Depressivity: A Transdiagnostic Machine Learning Study in Adolescents and Young Adults.Weyer C et al. Biol Psychiatry 2026. PMID 419164421 Zitationen
  33. Polygenic scores for executive functioning as predictors of performance improvements after repeated testing in major psychiatric disorders.Navarro-Flores A et al. Sci Rep 2026. PMID 418400261 Zitationen
  34. Protocol of the randomized double blind sham controlled AddVNS study of transcutaneous vagus nerve stimulation mechanisms in depression.LetztautorKokolakis E et al. Sci Rep 2026. PMID 41771997
  35. Risperidone-ISMeffectiveness and tolerability in acute schizophrenia patients hospitalised due to a relapse: results from an international, prospective, non-interventional evaluation (RESHAPE study).Correll CU et al. World J Biol Psychiatry 2026. PMID 417342743 Zitationen
  36. Rethinking schizophrenia: Optimizing care pathways in Europe from the first episode of psychosis to long-term care.Mohr P et al. Eur Psychiatry 2026. PMID 41693469
  37. The new S3 guideline on schizophrenia (living) 2025.Halms T et al. Nervenarzt 2026. PMID 41627392
  38. The link between GABA levels and P300 abnormalities in schizophrenia spectrum disorders: regional and symptom-based insights.Karslı B et al. Schizophrenia (Heidelb) 2026. PMID 415777051 Zitationen
  39. Biomarker innovations in precision psychiatry diagnostics and treatment strategies.Kas MJH et al. Eur Neuropsychopharmacol 2026. PMID 415445755 Zitationen
  40. Using multi-trait polygenic scores to predict lithium responsiveness in patients with bipolar disorder.Sharew NT et al. medRxiv 2026. Preprint PMID 41542698
  41. Brain and Mental Health Go Hand in Hand: A Look Back at a Year of Intensive Collaboration.LetztautorKuhn J, Falkai P. Fortschr Neurol Psychiatr 2026. PMID 41534533
  42. Reconceptualizing Schizophrenia through a Patient-Oriented Perspective: a Systematic Review and Qualitative Meta-Synthesis.Aprile SF et al. Schizophr Bull 2026. PMID 42786718
  43. The new German evidence- and consensus-based schizophrenia guideline.Hasan A et al. World Psychiatry 2026. PMID 42136437
  44. Responsible artificial intelligence integration framework for psychiatric guidelines.Mendlovic S et al. Int J Neuropsychopharmacol 2026. PMID 420287242 Zitationen
  45. Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia.Raabe FJ et al. JAMA Psychiatry 2026. PMID 419027542 Zitationen
  46. Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophrenia.Koutsouleris N et al. Brain 2026. PMID 418234132 Zitationen
  47. Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis.Popovic D et al. JAMA Psychiatry 2026. PMID 414059105 Zitationen
  48. Decoding Psychosis Risk: Neuroanatomical Correlates of the NAPLS-2 Calculator in the PRONIA Cohort.Neuner LM et al. Schizophr Bull 2026. PMID 40856416
  49. Correction: A multimodal approach to depression diagnosis: insights from machine learning algorithm development in primary care.LetztautorEder J et al. Eur Arch Psychiatry Clin Neurosci 2026. PMID 40601005
  50. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. Fortschr Neurol Psychiatr 2026. PMID 42887505

2025

  1. Mapping Neurochemical Signatures onto Brain Structure for Neurotransmitter-Informed Discrimination of Schizophrenia Patients from Healthy Controls.Hahn L et al. medRxiv 2025. Preprint PMID 41404274
  2. German Brain Council - Promoting brain health, treating brain diseases.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2025. PMID 41330406
  3. Clinical and Treatment Characteristics of 3795 Adults Consecutively Hospitalized for Major Depressive Disorder in the OASIS-D Study.Nöhles VB et al. Depress Anxiety 2025. PMID 413471111 Zitationen
  4. Clarifying the role of somatic and depressive symptoms in suicide risk: Evidence from a cross-sectional analysis.Volz R et al. J Psychosom Res 2025. PMID 412742171 Zitationen
  5. A psychometric evaluation of the German Revised-Green et al. Paranoid Thoughts Scale (R-GPTS) in clinical and non-clinical groups.Rek S et al. BMC Psychiatry 2025. PMID 41254569
  6. Reducing functional dysconnectivity in people with schizophrenia spectrum disorders.Wunderlich S et al. BJPsych Open 2025. PMID 412083962 Zitationen
  7. Multimodal biological profiles of symptom-based subgroups in recent-onset psychosis.LetztautorKoutsouleris N et al. Res Sq 2025. Preprint PMID 41282156
  8. The BMIgap tool to quantify transdiagnostic brain signatures of current and future weight.Khuntia A et al. Nat Ment Health 2025. PMID 412115311 Zitationen
  9. Neural and somatic mechanisms driving clinical improvements in post-acute schizophrenia spectrum disorders.LetztautorRoell L et al. Eur Psychiatry 2025. PMID 411400391 Zitationen
  10. Implementation of a patient-focused psychosocial intervention guideline for people with severe mental illness: Cluster-randomised controlled trial.Kösters M et al. Eur Psychiatry 2025. PMID 411266661 Zitationen
  11. Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.Howes OD et al. Am J Psychiatry 2025. PMID 4105823612 Zitationen
  12. Brain age gap reduction following exercise mirrors clinical improvements in schizophrenia spectrum disorders.Yilmaz D et al. Neuroimage Clin 2025. PMID 410670911 Zitationen
  13. Physical exercise therapy in schizophrenia spectrum disorders: current evidence and treatment recommendations.LetztautorRoell L et al. Neuropsychiatr 2025. PMID 409607271 Zitationen
  14. Comparing the proteome profiling of plasma-derived extracellular vesicles in individuals with schizophrenia and healthy controls: a pilot study.Oraki Kohshour M et al. Schizophr Res 2025. PMID 409453171 Zitationen
  15. Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.Yakimov V et al. Eur Arch Psychiatry Clin Neurosci 2025. PMID 409241032 Zitationen
  16. Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study.Serra-Navarro M et al. Acta Psychiatr Scand 2025. PMID 408994372 Zitationen
  17. Urban mental health: a position paper of the European psychiatric association.Misiak B et al. Eur Psychiatry 2025. PMID 408984034 Zitationen
  18. Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse Study.Solé B et al. Acta Psychiatr Scand 2025. PMID 40887816
  19. The ILIA study: protocol for a randomized-controlled multicenter clinical trial on smartphone- and web-based relapse monitoring for patients with schizophrenia or schizoaffective disorder.Hiller S et al. Eur Arch Psychiatry Clin Neurosci 2025. PMID 408284233 Zitationen
  20. iPSC-modelling reveals genetic associations and morphological alterations of oligodendrocytes in schizophrenia.Chang MH et al. Transl Psychiatry 2025. PMID 408190834 Zitationen
  21. PACIC: patient activation and problem solving not related to age in patients with depressive symptoms.Lukaschek K et al. Eur Arch Psychiatry Clin Neurosci 2025. PMID 40767953
  22. Association of psychosis and oral health: case-control study.Wölfle UC et al. Clin Oral Investig 2025. PMID 407648652 Zitationen
  23. Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspective.LetztautorRojnic Kuzman M et al. Eur Psychiatry 2025. PMID 407459104 Zitationen
  24. Predictors of social inclusion among adults with severe mental illness: Results of a cross-sectional study.Ohlhoff M et al. Int J Soc Psychiatry 2025. PMID 40743279
  25. From Snapshots to Stable Outcomes: Resting-State Functional Magnetic Resonance Imaging-Based Prognosis of Functioning in Patients With Psychosis Risk or Recent-Onset Depression.Buciuman MO et al. Biol Psychiatry 2025. PMID 40645362
  26. Pathway-Specific Polygenic Scores for Predicting Clinical Lithium Treatment Response in Patients With Bipolar Disorder.Sharew NT et al. Biol Psychiatry Glob Open Sci 2025. PMID 408213949 Zitationen
  27. Exploring the predictive value of structural covariance networks for the diagnosis of schizophrenia.Vetter CS et al. Front Psychiatry 2025. PMID 405518211 Zitationen
  28. Precision psychiatry roadmap: towards a biology-informed framework for mental disorders.Kas MJH et al. Mol Psychiatry 2025. PMID 4053354856 Zitationen
  29. Disease severity across psychiatric disorders is linked to pro-inflammatory cytokines.Solomon P et al. Brain Behav Immun 2025. PMID 4050582212 Zitationen
  30. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial - ERRATUM.Young AH et al. Br J Psychiatry 2025. PMID 40488357
  31. Determinants of physical activity and exercise in individuals with mental illness: results from a large cross-sectional online survey.Koepl KL et al. BMJ Open 2025. PMID 404844261 Zitationen
  32. Relationship between blood-cerebrospinal fluid barrier integrity, cardiometabolic, and inflammatory factors in schizophrenia-spectrum disorders.Yakimov V et al. Brain Behav Immun Health 2025. PMID 405297896 Zitationen
  33. How childhood adversities shape minds and lives: An analysis across the affective-to-psychotic spectrum.Greiner SK et al. Psychiatry Res 2025. PMID 404246472 Zitationen
  34. Evaluation of a Smartphone App Intervention with Telephone Guidance as Transitional Support from Inpatient Treatment to Continuing Care for Individuals with Alcohol Use Disorder: Results from a Randomized Controlled Trial.Saur S et al. Psychother Psychosom 2025. PMID 404142141 Zitationen
  35. Tourette syndrome: effects of acetyl-leucine in two individuals.Hofer EM et al. J Neurol 2025. PMID 40387962
  36. Needs of people with severe mental illness.Breilmann J et al. Nervenarzt 2025. PMID 40387900
  37. Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.Strom NI et al. Nat Genet 2025. PMID 4036080270 Zitationen
  38. Aggregating single nucleotide polymorphisms improves filtering for false-positive associations postimputation.Stahl K et al. G3 (Bethesda) 2025. PMID 400538322 Zitationen
  39. EEG-based Signatures of Schizophrenia, Depression, and Aberrant Aging: A Supervised Machine Learning Investigation.Sarisik E et al. Schizophr Bull 2025. PMID 3924826711 Zitationen
  40. Mental health services in Germany - Structures, outcomes and future challenges.Wiegand HF et al. Int Rev Psychiatry 2025. PMID 4070841214 Zitationen
  41. Assessment of the German Version of Brief Assessment of Cognition in Schizophrenia (BACS).Mortazavi M et al. Schizophr Res Cogn 2025. PMID 403861231 Zitationen
  42. Integrative analysis of miRNA expression profiles reveals distinct and common molecular mechanisms underlying broad diagnostic groups of severe mental disorders.Solomon P et al. Mol Psychiatry 2025. PMID 402635287 Zitationen
  43. How variants in inflammatory mediator genes influence symptom severity of psychiatric disorders: Findings from the PsyCourse study.Oraki Kohshour M et al. Psychiatry Res 2025. PMID 402396074 Zitationen
  44. Changing Psychiatric Terms - Why Schizophrenia Needs to be Renamed in the 21st Century.Böge K et al. Psychiatr Prax 2025. PMID 402163882 Zitationen
  45. How to measure functional connectivity using resting-state fMRI? A comprehensive empirical exploration of different connectivity metrics.Roell L et al. Neuroimage 2025. PMID 402162132 Zitationen
  46. Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls.Moussiopoulou J et al. Brain Behav Immun 2025. PMID 4019474822 Zitationen
  47. Measuring social environment factors of inpatients and outpatients with depression in Germany: a cross-sectional study.Schoenweger P et al. BMJ Ment Health 2025. PMID 401854923 Zitationen
  48. Mental health and mental healthcare as elements of pandemic and crisis preparedness.Wiegand HF et al. Nervenarzt 2025. PMID 40169414
  49. Aerobic exercise therapy in severe mental disorders: from methods to underlying mechanisms.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2025. PMID 40085249
  50. Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.Strom NI et al. medRxiv 2025. Preprint PMID 3871209119 Zitationen
  51. Pathway-Specific Polygenic Scores for Lithium Response for Predicting Clinical Lithium Treatment Response in Patients with Bipolar Disorder.Sharew NT et al. medRxiv 2025. Preprint PMID 401962731 Zitationen
  52. Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries.Fountoulakis KN et al. Psychiatry Res 2025. PMID 401796361 Zitationen
  53. Managing suicidal patients in general practices : A qualitative study on barriers and facilitating factors.Brand C et al. Nervenarzt 2025. PMID 40163192
  54. Investigating the association of the plasma lipidomic profile with cognitive performance and genetic risk in the PsyCourse study.Oraki Kohshour M et al. Transl Psychiatry 2025. PMID 401553811 Zitationen
  55. Vestibular dysfunction: a hidden risk factor for Alzheimer's disease.Koriath CAM et al. J Neurol 2025. PMID 401314803 Zitationen
  56. Characterizing of dropouts in the mental health of refugees and asylum seekers (MEHIRA) study examining the effects of a stepped and collaborative care model - a multicentered rater-blinded randomized controlled trial - CORRIGENDUM.Kemna S et al. Psychol Med 2025. PMID 40125777
  57. Suboptimal antidepressant use among inpatients and outpatients with symptoms of depression: a cross-sectional analysis of the POKAL core data set.Brisnik V et al. Eur Arch Psychiatry Clin Neurosci 2025. PMID 400725322 Zitationen
  58. A multimodal approach to depression diagnosis: insights from machine learning algorithm development in primary care.LetztautorEder J et al. Eur Arch Psychiatry Clin Neurosci 2025. PMID 400632592 Zitationen
  59. Effectiveness of pharmacological and non-pharmacological interventions for treatment-resistant depression in older patients: a systematic review and meta-analysis.Larsen AJ et al. BMJ Ment Health 2025. PMID 400325539 Zitationen
  60. Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders.Boudriot E et al. JAMA Psychiatry 2025. PMID 3977583313 Zitationen
  61. Developing the EPA guidance of pharmacological treatment of schizophrenia - results of a Delphi process.ErstautorFalkai P et al. Eur Psychiatry 2025. PMID 398825963 Zitationen
  62. Characterizing of dropouts in the mental health of refugees and asylum seekers (MEHIRA) study examining the effects of a stepped and collaborative care model - a multicentered rater-blinded randomized controlled trial.Kemna S et al. Psychol Med 2025. PMID 397732582 Zitationen
  63. Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials.Keefe RSE et al. Lancet Psychiatry 2025. PMID 4123308313 Zitationen
  64. Periodic and Aperiodic Alterations of Resting-State EEG in Schizophrenia Spectrum Disorders: Cognitive and Clinical Insights.Hasanaj G et al. Eur J Neurosci 2025. PMID 410451011 Zitationen
  65. Testing a Motor Score Based on PANSS Ratings: A Proxy for Comprehensive Motor Assessment.Nadesalingam N et al. Schizophr Bull 2025. PMID 392227184 Zitationen
  66. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. MMW Fortschr Med 2025. PMID 40237980

2024

  1. Towards collaborative data science in mental health research: The ECNP neuroimaging network accessible data repository.Khuntia A et al. Neurosci Appl 2024. PMID 406545931 Zitationen
  2. Reasons to move-a cross-sectional study to identify factors promoting regular exercise.Wambsganz A et al. Front Sports Act Living 2024. PMID 397227432 Zitationen
  3. Lost and found: dynamics of relationship and employment status over time in people with affective and psychotic spectrum disorders.Senner F et al. BJPsych Open 2024. PMID 397219611 Zitationen
  4. Contrasting genetic burden for bipolar disorder: Early onset versus late onset in an older adult bipolar disorder sample.Montejo L et al. Eur Neuropsychopharmacol 2024. PMID 397180745 Zitationen
  5. BMIgap: a new tool to quantify transdiagnostic brain signatures of current and future weight.Koutsouleris N et al. Res Sq 2024. Preprint PMID 39711565
  6. Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal study.Yakimov V et al. Schizophrenia (Heidelb) 2024. PMID 3970685110 Zitationen
  7. EPA guidance on lifestyle interventions for adults with severe mental illness: A meta-review of the evidence.LetztautorMaurus I et al. Eur Psychiatry 2024. PMID 3965599938 Zitationen
  8. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial.Young AH et al. Br J Psychiatry 2024. PMID 396182374 Zitationen
  9. Cognitive impairments associated with schizophrenic psychoses : Diagnostics, course and therapy.Kambeitz-Ilankovic L et al. Nervenarzt 2024. PMID 395895031 Zitationen
  10. Effects of aerobic exercise on hippocampal formation volume in people with schizophrenia - a systematic review and meta-analysis with original data from a randomized-controlled trial.Roell L et al. Psychol Med 2024. PMID 395523959 Zitationen
  11. Early Treatment-Resistance in First Episode Psychosis.Fernando P et al. Pharmacopsychiatry 2024. PMID 395477041 Zitationen
  12. The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophrenia.Bitter I et al. Eur Arch Psychiatry Clin Neurosci 2024. PMID 395355511 Zitationen
  13. The weight of office? A scoping review of mental health issues and risk factors in elected politicians across democratic societies.Smith A et al. Int J Soc Psychiatry 2024. PMID 395351384 Zitationen
  14. Housing Situation of People with Severe Mental Illnesses.Lamp N et al. Psychiatr Prax 2024. PMID 395153731 Zitationen
  15. Temporal interaction of suicidal ideations and behaviors with loneliness in persistent depressive disorder - a feasibility study using ecological momentary assessment.Wolf J et al. Eur Arch Psychiatry Clin Neurosci 2024. PMID 394886395 Zitationen
  16. Predictors of symptom change in the mental health of refugees and asylum seekers (MEHIRA) study examining the effects of a stepped and collaborative care model - A multicentered rater-blinded randomized controlled trial.Kemna S et al. J Affect Disord 2024. PMID 394904231 Zitationen
  17. Self-help offers for people with severe mental illness: who uses which format?.Richter D et al. Nervenarzt 2024. PMID 39438290
  18. Intermittent theta burst stimulation in adolescents and young adults with depressive disorders: protocol of a randomized, sham-controlled study with a sequential Bayesian design for adaptive trials.Burkhardt G et al. Eur Arch Psychiatry Clin Neurosci 2024. PMID 393879181 Zitationen
  19. Cell type-specific polygenic burden modulates exercise effects in schizophrenia patients: further evidence on volumes of hippocampal subfields.LetztautorPapiol S et al. Eur Arch Psychiatry Clin Neurosci 2024. PMID 389650912 Zitationen
  20. Impact of excessive abdominal obesity on brain microstructural abnormality in schizophrenia.Yamada S et al. Psychiatry Res Neuroimaging 2024. PMID 392268691 Zitationen
  21. Dose-Dependent Target Engagement of a Clinical Intermittent Theta Burst Stimulation Protocol: An Interleaved Transcranial Magnetic Stimulation-Functional Magnetic Resonance Imaging Study in Healthy People.Chang KY et al. Biol Psychiatry Cogn Neurosci Neuroimaging 2024. PMID 391827239 Zitationen
  22. Modulation of Neuronal Excitability and Plasticity by BHLHE41 Conveys Lithium Non-Responsiveness.Stephan M et al. bioRxiv 2024. Preprint PMID 393727971 Zitationen
  23. The impact of a digital guideline version on schizophrenia guideline knowledge: results from a multicenter cluster-randomized controlled trial.Halms T et al. BMC Med 2024. PMID 390754583 Zitationen
  24. Distinct genetic liability profiles define clinically relevant patient strata across common diseases.Trastulla L et al. Nat Commun 2024. PMID 389515129 Zitationen
  25. Assessment of university psychiatry and psychotherapy in Germany: Responsibilities and challenges : Position paper of the Lehrstuhlinhaber für Psychiatrie und Psychotherapie e. V. (LIPPs) in Germany.ErstautorFalkai P et al. Nervenarzt 2024. PMID 38904789
  26. Why is it so difficult to implement precision psychiatry into clinical care?ErstautorFalkai P, Koutsouleris N. Lancet Reg Health Eur 2024. PMID 388833085 Zitationen
  27. Exploring the genetics of lithium response in bipolar disorders.Herrera-Rivero M et al. Int J Bipolar Disord 2024. PMID 3886503912 Zitationen
  28. Two Sides of the Same Coin in Female Borderline Personality Disorder: Self-Reported Guilt and Shame and Their Neurofunctional Correlates.Parpart H et al. Brain Sci 2024. PMID 38928549
  29. Climate change and mental health: Position paper of the European Psychiatric Association.Brandt L et al. Eur Psychiatry 2024. PMID 3877803121 Zitationen
  30. Discharged, but where to? The Current Situation of Long Stay Patients in German Psychiatric Clinics.Jenderny S et al. Psychiatr Prax 2024. PMID 387494545 Zitationen
  31. Characterization of cognitive symptoms in post COVID-19 patients.Ruzicka M et al. Eur Arch Psychiatry Clin Neurosci 2024. PMID 3873926314 Zitationen
  32. Providing Cognitive Remediation Therapy to People with Schizophrenia: Results of a Survey in Psychiatric Clinics in Germany.Schuster T et al. Fortschr Neurol Psychiatr 2024. PMID 38718816
  33. Comparative electroencephalography analysis: Marathon runners during tapering versus sedentary controls reveals no significant differences.Moussiopoulou J et al. Brain Behav 2024. PMID 386800192 Zitationen
  34. Assessing the impact of sex on high-frequency repetitive transcranial magnetic stimulation´s clinical response in schizophrenia - results from a secondary analysis.Campana M et al. World J Biol Psychiatry 2024. PMID 384933623 Zitationen
  35. Signature of Altered Retinal Microstructures and Electrophysiology in Schizophrenia Spectrum Disorders Is Associated With Disease Severity and Polygenic Risk.Boudriot E et al. Biol Psychiatry 2024. PMID 3867935822 Zitationen
  36. Multimodal workflows optimally predict response to repetitive transcranial magnetic stimulation in patients with schizophrenia: a multisite machine learning analysis.Dong MS et al. Transl Psychiatry 2024. PMID 3866437714 Zitationen
  37. Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.Campana M et al. Brain Behav Immun 2024. PMID 3860874211 Zitationen
  38. Who is at risk for weight gain after weight-gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach.Eder J et al. Acta Psychiatr Scand 2024. PMID 385612356 Zitationen
  39. Distinct multimodal biological and functional profiles of symptom-based subgroups in recent-onset psychosis.LetztautorKoutsouleris N et al. Res Sq 2024. Preprint PMID 385590143 Zitationen
  40. Predictors of adherence to exercise interventions in people with schizophrenia.Schwaiger R et al. Eur Arch Psychiatry Clin Neurosci 2024. PMID 385517739 Zitationen
  41. Characterizing cognitive subtypes in schizophrenia using cortical curvature.Papazova I et al. J Psychiatr Res 2024. PMID 385311432 Zitationen
  42. Regulation of Zbp1 by miR-99b-5p in microglia controls the development of schizophrenia-like symptoms in mice.Kaurani L et al. EMBO J 2024. PMID 3852818214 Zitationen
  43. The German Center for Mental Health : Innovative translational research to promote prevention, targeted intervention and resilience.Halil MG et al. Nervenarzt 2024. PMID 384890283 Zitationen
  44. Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries.Rojnic Kuzman M et al. Eur Psychiatry 2024. PMID 384506516 Zitationen
  45. Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study.Ou AH et al. Transl Psychiatry 2024. PMID 3839590619 Zitationen
  46. Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study.Fountoulakis KN et al. J Affect Disord 2024. PMID 383828161 Zitationen
  47. Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study).Fountoulakis KN et al. CNS Spectr 2024. PMID 3826957411 Zitationen
  48. Polygenic risk for schizophrenia converges on alternative polyadenylation as molecular mechanism underlying synaptic impairment.Raabe FJ et al. bioRxiv 2024. Preprint PMID 382605775 Zitationen
  49. Effects of Exercise on Structural and Functional Brain Patterns in Schizophrenia-Data From a Multicenter Randomized-Controlled Study.Roell L et al. Schizophr Bull 2024. PMID 3759750710 Zitationen

2023

  1. Digital technology and mental health during the COVID-19 pandemic: a narrative review with a focus on depression, anxiety, stress, and trauma.Guest PC et al. Front Psychiatry 2023. PMID 381880497 Zitationen
  2. Deconstructing depression by machine learning: the POKAL-PSY study.LetztautorEder J et al. Eur Arch Psychiatry Clin Neurosci 2023. PMID 380910845 Zitationen
  3. Digitalising mental health care: Practical recommendations from the European Psychiatric Association.LetztautorKalman JL et al. Eur Psychiatry 2023. PMID 3808674420 Zitationen
  4. Exploring the genetics of lithium response in bipolar disorders.Herrera-Rivero M et al. Res Sq 2023. Preprint PMID 380770402 Zitationen
  5. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis.Siafis S et al. Lancet Psychiatry 2023. PMID 3804356220 Zitationen
  6. The influence of marathon running on resting-state EEG activity: a longitudinal observational study.Moussiopoulou J et al. Eur J Appl Physiol 2023. PMID 380193172 Zitationen
  7. Ethical dilemmas in contemporary psychiatry: Findings from a survey of National Psychiatric Associations in Europe.Samochowiec J et al. Eur Psychiatry 2023. PMID 379094133 Zitationen
  8. Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis.ErstautorFalkai P et al. Schizophr Bull 2023. PMID 3716367524 Zitationen
  9. Adverse childhood experiences and clinical effects of transcranial direct current stimulation in major depressive disorder: Results from the DepressionDC trial.Burkhardt G et al. Psychiatry Res 2023. PMID 37922733
  10. Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study.Kelsoe J et al. Res Sq 2023. Preprint PMID 378865631 Zitationen
  11. Transdiagnostic analysis of adverse childhood experiences and their association with psychopathology-A TRANS-D conform study.Goerigk S et al. Psychiatry Res 2023. PMID 3787920015 Zitationen
  12. Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomes.Nöhles VB et al. BMC Psychiatry 2023. PMID 378284933 Zitationen
  13. Influence of guideline recommendations, care structures and individual factors on the use of psychosocial therapies in severely mentally ill people.Fritz S et al. Psychiatr Prax 2023. PMID 378133636 Zitationen
  14. Sports Therapy for Schizophrenia Psychoses: from the Idea to the Guideline.ErstautorFalkai P et al. Gesundheitswesen 2023. PMID 377517603 Zitationen
  15. Targeting metacognitive change mechanisms in acute inpatients with psychotic symptoms: feasibility and acceptability of a modularized group intervention.Gussmann E et al. Eur Arch Psychiatry Clin Neurosci 2023. PMID 377419461 Zitationen
  16. Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial.LetztautorMaurus I et al. Psychiatry Res 2023. PMID 3771632035 Zitationen
  17. Anti-amyloid antibody treatments for Alzheimer's disease.Perneczky R et al. Eur J Neurol 2023. PMID 3769771478 Zitationen
  18. Cellular pathology in the limbic system in schizophrenia.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2023. PMID 375425594 Zitationen
  19. Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II.ErstautorFalkai P, Dombi ZB. Front Psychiatry 2023. PMID 37671286
  20. Conventional and living guideline for schizophrenia: barriers and facilitating factors in guideline implementation.Lorenz C et al. Eur Arch Psychiatry Clin Neurosci 2023. PMID 375816911 Zitationen
  21. Higher Subjective Burden in Psychiatric Compared to Somatic Healthcare Workers in Germany During the first wave of the COVID-19 Pandemic.Halms T et al. Fortschr Neurol Psychiatr 2023. PMID 37567248
  22. Improving mental health care in depression: A call for action.LetztautorEder J et al. Eur Psychiatry 2023. PMID 3753440210 Zitationen
  23. The Interplay of Oxytocin and Attachment in Schizophrenic Patients: An fMRI Study.Hennig-Fast K et al. Brain Sci 2023. PMID 376264822 Zitationen
  24. A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients.Seemüller F et al. BMC Psychiatry 2023. PMID 3750765657 Zitationen
  25. Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial.Wagner E et al. Pharmacopsychiatry 2023. PMID 375067389 Zitationen
  26. The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning.Theisen C et al. Front Psychiatry 2023. PMID 374846692 Zitationen
  27. The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia.LetztautorMisiak B et al. Eur Psychiatry 2023. PMID 3747697722 Zitationen
  28. Germany's hospital reform: possible consequences for psychiatry and psychotherapy.ErstautorFalkai P, Gaebel W. Fortschr Neurol Psychiatr 2023. PMID 374635741 Zitationen
  29. Empowerment group therapy for refugees with affective disorders: results of a multicenter randomized controlled trial.Wiechers M et al. Eur Psychiatry 2023. PMID 374582159 Zitationen
  30. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.Amare AT et al. Mol Psychiatry 2023. PMID 3743396736 Zitationen
  31. Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial.Burkhardt G et al. Lancet 2023. PMID 3741406465 Zitationen
  32. Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT).Bechdolf A et al. Schizophr Bull 2023. PMID 3702166618 Zitationen
  33. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.Wagner E et al. Schizophr Bull 2023. PMID 3694324734 Zitationen
  34. Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder.Herrera-Rivero M et al. Res Sq 2023. Preprint PMID 374617193 Zitationen
  35. Overarching aspects of guidelines.ErstautorFalkai P, Pfennig A. Nervenarzt 2023. PMID 37378803
  36. Shared sorrow, shared costs: cost-effectiveness analysis of thegroup therapy approach to treat affective disorders in refugee populations.Strupf M et al. BJPsych Open 2023. PMID 373455443 Zitationen
  37. Structural and Functional Brain Patterns Predict Formal Thought Disorder's Severity and Its Persistence in Recent-Onset Psychosis: Results From the PRONIA Study.Buciuman MO et al. Biol Psychiatry Cogn Neurosci Neuroimaging 2023. PMID 373436615 Zitationen
  38. Developing a mechanism-based therapy for acute psychiatric inpatients with psychotic symptoms: an Intervention Mapping approach.Gussmann E et al. Front Psychiatry 2023. PMID 373248202 Zitationen
  39. Introduction for the follow-up of the Eighth International Kraepelin Symposium at LMU Munich.LetztautorAnnette S, Falkai P. Eur Arch Psychiatry Clin Neurosci 2023. PMID 37199806
  40. The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research.Krčmář L et al. Front Psychiatry 2023. PMID 3721566118 Zitationen
  41. Distinct genetic liability profiles define clinically relevant patient strata across common diseases.Trastulla L et al. medRxiv 2023. Preprint PMID 372148981 Zitationen
  42. Synchrony in psychotherapy: High physiological positive concordance predicts symptom reduction and negative concordance predicts symptom aggravation.Gernert CC et al. Int J Methods Psychiatr Res 2023. PMID 3720494012 Zitationen
  43. 45 years German Society of Biological Psychiatry (DGBP).LetztautorRiederer P et al. J Neural Transm (Vienna) 2023. PMID 37142786
  44. COVID-19 vaccination for people with severe mental diseases : Results of the COVID Ψ outpatient survey and recommendations for psychiatry.Wiegand HF et al. Nervenarzt 2023. PMID 37138091
  45. Publishing Negative Results of Neurobiological Studies in Mental Disorders Will Advance Knowledge in Pathophysiology.LetztautorSteiner J et al. Schizophr Bull 2023. PMID 368528403 Zitationen
  46. Patterns of risk-Using machine learning and structural neuroimaging to identify pedophilic offenders.Popovic D et al. Front Psychiatry 2023. PMID 371519665 Zitationen
  47. Smoking status ameliorates cholinergic impairments in cortical inhibition in patients with schizophrenia.Pross B et al. Brain Res 2023. PMID 371214252 Zitationen
  48. The Goldwater Rule at 50 and its relevance in Europe: Examining the positions of National Psychiatric Association Members of the European Psychiatric Association.Smith A et al. Eur Psychiatry 2023. PMID 3709235414 Zitationen
  49. The relationship between blood-brain barrier dysfunction and neurocognitive impairments in first-episode psychosis: findings from a retrospective chart analysis.Maurus I et al. BJPsych Open 2023. PMID 370387608 Zitationen
  50. Treatment of negative symptoms in schizophrenia: a challenge for clinical research.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2023. PMID 369777884 Zitationen
  51. Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study.Senner F et al. Transl Psychiatry 2023. PMID 3696616912 Zitationen
  52. Blood-brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review.Campana M et al. Eur Arch Psychiatry Clin Neurosci 2023. PMID 3686923413 Zitationen
  53. Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism.N Fountoulakis K et al. Soc Psychiatry Psychiatr Epidemiol 2023. PMID 3686722416 Zitationen
  54. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder.Tkachev A et al. JAMA Psychiatry 2023. PMID 3669610159 Zitationen
  55. High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon.Schoenfeld J et al. Front Physiol 2023. PMID 368661783 Zitationen
  56. Association of early life stress and cognitive performance in patients with schizophrenia and healthy controls.Senner F et al. Schizophr Res Cogn 2023. PMID 368464897 Zitationen
  57. Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder.Amare A et al. Res Sq 2023. Preprint PMID 368249222 Zitationen
  58. Guideline for schizophrenia: implementation status and attitude toward an upcoming living guideline.Khorikian-Ghazari N et al. Eur Arch Psychiatry Clin Neurosci 2023. PMID 3680853310 Zitationen
  59. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.Merritt K et al. Mol Psychiatry 2023. PMID 3680676269 Zitationen
  60. Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review.LetztautorMöller HJ, Falkai P. Eur Arch Psychiatry Clin Neurosci 2023. PMID 3679057712 Zitationen
  61. Depressive primary care patients' assessment of received collaborative care.Lukaschek K et al. Sci Rep 2023. PMID 367596223 Zitationen
  62. Delusions - forms, causes and treatment options.LetztautorMoussiopoulou J, Falkai P. MMW Fortschr Med 2023. PMID 36759476
  63. Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex.Matosin N et al. Acta Neuropathol 2023. PMID 3672913347 Zitationen
  64. The Neurobiological and Epigenetic Links Between Negative Life Events and Behavioral Disturbances in Adolescent Youth.LetztautorPopovic D, Falkai P. Biol Psychiatry 2023. PMID 36653106
  65. WPA's humanitarian actions for Ukrainian psychiatrists and psychiatric patients.Wasserman D et al. World Psychiatry 2023. PMID 366404021 Zitationen
  66. Diversity in Neurology and Psychiatry.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2023. PMID 36693364
  67. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.David FS et al. Schizophr Res 2023. PMID 3665283324 Zitationen
  68. Association between mitochondria-related genes and cognitive performance in the PsyCourse Study.Oraki Kohshour M et al. J Affect Disord 2023. PMID 366216763 Zitationen
  69. Supporting return to work after psychiatric hospitalization-A cluster randomized study (RETURN-study).Hamann J et al. Eur Psychiatry 2023. PMID 366210095 Zitationen
  70. Beitrag ohne Titelangabe in PubMedYakimov V et al. Fortschr Neurol Psychiatr 2023. PMID 37725988
  71. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. MMW Fortschr Med 2023. PMID 36759445

2022

  1. Innovations in psychiatry: challenges and future directions.LetztautorFiorillo A et al. Int Rev Psychiatry 2022. PMID 365861243 Zitationen
  2. Kalpra: A kernel approach for longitudinal pathway regression analysis integrating network information with an application to the longitudinal PsyCourse Study.Wendel B et al. Front Genet 2022. PMID 365613121 Zitationen
  3. Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein.Dening Y et al. Sci Rep 2022. PMID 365359746 Zitationen
  4. Predictors and outcomes in primary depression care (POKAL) - a research training group develops an innovative approach to collaborative care.Gensichen J et al. BMC Prim Care 2022. PMID 3646096514 Zitationen
  5. Predicting treatment outcomes of the Empowerment group intervention for refugees with affective disorders: Findings from the MEHIRA project.Strupf M et al. J Affect Disord 2022. PMID 364276527 Zitationen
  6. Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.Strube W et al. J Neural Transm (Vienna) 2022. PMID 364017498 Zitationen
  7. Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors.Schmitt A et al. J Neural Transm (Vienna) 2022. PMID 3637018372 Zitationen
  8. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.Oraki Kohshour M et al. Transl Psychiatry 2022. PMID 363518926 Zitationen
  9. Reduced cortical neuron number and neuron density in schizophrenia with focus on area 24: a post-mortem case-control study.Gaus R et al. Eur Arch Psychiatry Clin Neurosci 2022. PMID 3635037613 Zitationen
  10. Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study.Schmitt A et al. Cells 2022. PMID 3629110915 Zitationen
  11. Editorial: New trends in psychiatric research: Toward the clinical characterization of the individual case and the personalization of treatments.Sampogna G et al. Front Psychiatry 2022. PMID 362763332 Zitationen
  12. Clinical decision-making style preferences of European psychiatrists: Results from the Ambassadors survey in 38 countries.Rojnic Kuzman M et al. Eur Psychiatry 2022. PMID 3626674212 Zitationen
  13. European Psychiatric Association-European Academy of Neurology statement on post-COVID syndrome.LetztautorBassetti CLA et al. Eur J Neurol 2022. PMID 361488284 Zitationen
  14. Post-mortem gene expression of calcium channels Cav1.2 and Cav1.3 in schizophrenia.Schmitt A et al. Eur Arch Psychiatry Clin Neurosci 2022. PMID 360666624 Zitationen
  15. Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat.Stephan M et al. Schizophrenia (Heidelb) 2022. PMID 3617142111 Zitationen
  16. Correction: Necessity and Ways to Develop Care Goals for the Health System in Germany - a Position Paper of the DNVF.Neugebauer E et al. Gesundheitswesen 2022. PMID 36170866
  17. Structured implementation of digital, systematically updated guideline recommendations for enhanced adherence in schizophrenia (SISYPHOS)-protocol of a cluster-randomized trial.Lorenz C et al. Trials 2022. PMID 361535555 Zitationen
  18. Fitness is positively associated with hippocampal formation subfield volumes in schizophrenia: a multiparametric magnetic resonance imaging study.LetztautorMaurus I et al. Transl Psychiatry 2022. PMID 3611418413 Zitationen
  19. European Psychiatric Association-European Academy of Neurology statement on post-COVID syndrome.LetztautorBassetti CLA et al. Eur Psychiatry 2022. PMID 360730953 Zitationen
  20. Necessity and Ways to Develop Care Goals for the Health System in Germany - a Position Paper of the DNVF.Neugebauer E et al. Gesundheitswesen 2022. PMID 360677786 Zitationen
  21. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited.Koutsouleris N et al. JAMA Psychiatry 2022. PMID 3592110430 Zitationen
  22. From conventional to living guidelines - faster updates for better informed guidance? A scoping review.Pielenz C et al. Z Evid Fortbild Qual Gesundhwes 2022. PMID 3604198310 Zitationen
  23. Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis.Müller H et al. Schizophrenia (Heidelb) 2022. PMID 360024477 Zitationen
  24. Patient Preferences for Exercise Therapy in People with Severe Mental Illness in Germany.Richter D et al. Fortschr Neurol Psychiatr 2022. PMID 35961322
  25. Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders.Boudriot E et al. Eur Arch Psychiatry Clin Neurosci 2022. PMID 3593003131 Zitationen
  26. Associations between aerobic fitness, negative symptoms, cognitive deficits and brain structure in schizophrenia-a cross-sectional study.LetztautorMaurus I et al. Schizophrenia (Heidelb) 2022. PMID 3591834411 Zitationen
  27. Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM.Cearns M et al. Br J Psychiatry 2022. PMID 355055156 Zitationen
  28. Biobanking in everyday clinical practice in psychiatry-The Munich Mental Health Biobank.Kalman JL et al. Front Psychiatry 2022. PMID 3593543113 Zitationen
  29. Identifying potential mechanisms between childhood trauma and the psychological response to the COVID-19 pandemic in Germany: a longitudinal study.Rek SV et al. Sci Rep 2022. PMID 359027029 Zitationen
  30. The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.Fountoulakis KN et al. Psychiatry Res 2022. PMID 3583963925 Zitationen
  31. Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.Schubert KO et al. Transl Psychiatry 2022. PMID 358177692 Zitationen
  32. Clinical, Brain, and Multilevel Clustering in Early Psychosis and Affective Stages.Dwyer DB et al. JAMA Psychiatry 2022. PMID 3558390328 Zitationen
  33. COVID-19 vaccination rates in hospitalized mentally ill patients compared to the general population in Germany: Results from the COVID Ψ Vac study.Wiegand HF et al. Eur Psychiatry 2022. PMID 357620464 Zitationen
  34. Anodal transcranial direct current stimulation sustainably increases EEG alpha activity in patients with schizophrenia.Pross B et al. Neuropsychopharmacol Rep 2022. PMID 357161225 Zitationen
  35. Effectiveness and cost-effectiveness for the treatment of depressive symptoms in refugees and asylum seekers: A multi-centred randomized controlled trial.Böge K et al. Lancet Reg Health Eur 2022. PMID 3569465318 Zitationen
  36. Brain Health and Mental Health: Two Sides of the Same Coin.LetztautorGaebel W, Falkai P. Fortschr Neurol Psychiatr 2022. PMID 35584689
  37. A novel longitudinal clustering approach to psychopathology across diagnostic entities in the hospital-based PsyCourse study.Schulte EC et al. Schizophr Res 2022. PMID 355678717 Zitationen
  38. Changes and Challenges in Inpatient Mental Health Care During the First Two High Incidence Phases of the COVID-19 Pandemic in Germany - Results From the COVID Ψ Psychiatry Survey.Wiegand HF et al. Front Psychiatry 2022. PMID 3557338013 Zitationen
  39. Association between aerobic fitness and the functional connectome in patients with schizophrenia.LetztautorRoell L et al. Eur Arch Psychiatry Clin Neurosci 2022. PMID 354880549 Zitationen
  40. Failed regeneration and inflammation in schizophrenia: two sides of the same coin?ErstautorFalkai P, Schmitt A. J Neural Transm (Vienna) 2022. PMID 354516574 Zitationen
  41. Psychiatry: Peter Falkai.AlleinautorFalkai P. J Neural Transm (Vienna) 2022. PMID 35389107
  42. Genetic variants associated with longitudinal changes in brain structure across the lifespan.Brouwer RM et al. Nat Neurosci 2022. PMID 35383335173 Zitationen
  43. Novel Gyrification Networks Reveal Links with Psychiatric Risk Factors in Early Illness.Sanfelici R et al. Cereb Cortex 2022. PMID 345193517 Zitationen
  44. Concept of the Munich/Augsburg Consortium Precision in Mental Health for the German Center of Mental Health.ErstautorFalkai P et al. Front Psychiatry 2022. PMID 353088712 Zitationen
  45. Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis.Penzel N et al. Schizophrenia (Heidelb) 2022. PMID 352646312 Zitationen
  46. Stability over time of scores on psychiatric rating scales, questionnaires and cognitive tests in healthy controls.Stahl K et al. BJPsych Open 2022. PMID 352325135 Zitationen
  47. The psychotic patient.LetztautorHandrack-Bonnet M et al. MMW Fortschr Med 2022. PMID 35211911
  48. Unstable Belief Formation and Slowed Decision-making: Evidence That the Jumping-to-Conclusions Bias in Schizophrenia Is Not Linked to Impulsive Decision-making.Strube W et al. Schizophr Bull 2022. PMID 345542608 Zitationen
  49. App-based maintenance treatment for alcohol use disorder after acute inpatient treatment: Study protocol for a multicentre randomized controlled trial.Saur S et al. Internet Interv 2022. PMID 352519406 Zitationen
  50. Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach.Cearns M et al. Br J Psychiatry 2022. PMID 3522575635 Zitationen
  51. The role of migration in mental healthcare: treatment satisfaction and utilization.Gaigl G et al. BMC Psychiatry 2022. PMID 351685724 Zitationen
  52. Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression.Antonucci LA et al. Br J Psychiatry 2022. PMID 351529239 Zitationen
  53. Investigating the phenotypic and genetic associations between personality traits and suicidal behavior across major mental health diagnoses.Kalman JL et al. Eur Arch Psychiatry Clin Neurosci 2022. PMID 351465714 Zitationen
  54. Lower Emotion Regulation Competencies Mediate the Association between Impulsivity and Craving during Alcohol Withdrawal Treatment.Reichl D et al. Subst Use Misuse 2022. PMID 351425995 Zitationen
  55. Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study.Kirchner SK et al. Front Psychiatry 2022. PMID 3512619115 Zitationen
  56. Power Factors and Success Probability in Psychiatry and Neurology.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2022. PMID 35081644
  57. Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte Differentiation.Raabe FJ et al. Cells 2022. PMID 3505335712 Zitationen
  58. Association of impulsivity with quality of life and well-being after alcohol withdrawal treatment.Reichl D et al. J Clin Psychol 2022. PMID 350451884 Zitationen
  59. Predictors of competitive employment in individuals with severe mental illness: results from an observational, cross-sectional study in Germany.Gühne U et al. J Occup Med Toxicol 2022. PMID 3504251112 Zitationen
  60. Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder-A Retrospective Chart Review.Campana M et al. Schizophr Bull 2022. PMID 3448047626 Zitationen

2021

  1. Characterisation of age and polarity at onset in bipolar disorder.Kalman JL et al. Br J Psychiatry 2021. PMID 3504887643 Zitationen
  2. The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials.ErstautorFalkai P et al. CNS Spectr 2021. PMID 350126967 Zitationen
  3. Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia.Yamada S et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 3493507214 Zitationen
  4. A Primeval Mechanism of Tolerance to Desiccation Based on Glycolic Acid Saves Neurons in Mammals from Ischemia by Reducing Intracellular Calcium-Mediated Excitotoxicity.Chovsepian A et al. Adv Sci (Weinh) 2021. PMID 3490440216 Zitationen
  5. Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables.Oviedo-Salcedo T et al. Transl Psychiatry 2021. PMID 3488021315 Zitationen
  6. Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine.ErstautorFalkai P et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 3487363523 Zitationen
  7. Peer Support: Utilization and Benefit in Severe Mental Illness - Results from an Observational, Cross-Sectional Study.Gühne U et al. Psychother Psychosom Med Psychol 2021. PMID 348721532 Zitationen
  8. Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study.Coombes BJ et al. Complex Psychiatry 2021. PMID 3640812723 Zitationen
  9. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.Schubert KO et al. Transl Psychiatry 2021. PMID 3484519049 Zitationen
  10. Polygenic risk scores across the extended psychosis spectrum.Smigielski L et al. Transl Psychiatry 2021. PMID 3483693925 Zitationen
  11. The ICD-11 is coming to town! Educational needs, paradigm shifts and innovations in mental health care practice.LetztautorFiorillo A, Falkai P. Eur Psychiatry 2021. PMID 348149541 Zitationen
  12. Chronic vs non-chronic depression in psychiatric inpatient care - Data from a large naturalistic multicenter trial.Seemüller F et al. J Affect Disord 2021. PMID 3480057511 Zitationen
  13. Interplay between the Genetics of Personality Traits, severe Psychiatric Disorders, and COVID-19 Host Genetics in the Susceptibility to SARS-CoV-2 Infection - ADDENDUM.Heilbronner U et al. BJPsych Open 2021. PMID 34789355
  14. Results of the COVID-19 mental health international for the general population (COMET-G) study.Fountoulakis KN et al. Eur Neuropsychopharmacol 2021. PMID 34758422102 Zitationen
  15. Interplay between the genetics of personality traits, severe psychiatric disorders and COVID-19 host genetics in the susceptibility to SARS-CoV-2 infection.Heilbronner U et al. BJPsych Open 2021. PMID 346597943 Zitationen
  16. A microRNA signature that correlates with cognition and is a target against cognitive decline.Islam MR et al. EMBO Mol Med 2021. PMID 3463314658 Zitationen
  17. Exercise as a model to identify microRNAs linked to human cognition: a role for microRNA-409 and microRNA-501.Goldberg M et al. Transl Psychiatry 2021. PMID 3462553620 Zitationen
  18. Correction to: Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial.LetztautorMaurus I et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 342269501 Zitationen
  19. Improvement in daily functioning after aerobic exercise training in schizophrenia is sustained after exercise cessation.ErstautorFalkai P et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 3414328715 Zitationen
  20. Effects of Marathon Running on Cognition and Retinal Vascularization: A Longitudinal Observational Study.Roeh A et al. Med Sci Sports Exerc 2021. PMID 340336207 Zitationen
  21. Genetic risk for psychiatric illness is associated with the number of hospitalizations of bipolar disorder patients.Kalman JL et al. J Affect Disord 2021. PMID 346560409 Zitationen
  22. Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.Wagner E et al. Transl Psychiatry 2021. PMID 34552059138 Zitationen
  23. The clinical relevance of formal thought disorder in the early stages of psychosis: results from the PRONIA study.Oeztuerk OF et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 3453581318 Zitationen
  24. HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders.Le Clerc S et al. Sci Rep 2021. PMID 3449727822 Zitationen
  25. The COVID-19 Pandemic Mental Health Questionnaire (CoPaQ): psychometric evaluation and compliance with countermeasures in psychiatric inpatients and non-clinical individuals.Rek SV et al. BMC Psychiatry 2021. PMID 3446531923 Zitationen
  26. In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.Wratil PR et al. Infection 2021. PMID 3437930818 Zitationen
  27. The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study.Smigielski L et al. Schizophr Bull 2021. PMID 338762496 Zitationen
  28. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.Koutsouleris N et al. Biol Psychiatry 2021. PMID 3448295145 Zitationen
  29. Decreased Serum Brain-Derived Neurotrophic Factor Concentrations 72 Hours Following Marathon Running.Roeh A et al. Front Physiol 2021. PMID 343352917 Zitationen
  30. Brief Report: Specificity of Interpersonal Synchrony Deficits to Autism Spectrum Disorder and Its Potential for Digitally Assisted Diagnostics.Koehler JC et al. J Autism Dev Disord 2021. PMID 3433162926 Zitationen
  31. Differential psychological response to the COVID-19 pandemic in psychiatric inpatients compared to a non-clinical population from Germany.Rek SV et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 3426861815 Zitationen
  32. A genome-wide association study of the longitudinal course of executive functions.Wendel B et al. Transl Psychiatry 2021. PMID 3424718621 Zitationen
  33. The progression of disorder-specific brain pattern expression in schizophrenia over 9 years.Lieslehto J et al. NPJ Schizophr 2021. PMID 3412767823 Zitationen
  34. Inpatient Psychiatric Treatment in the Corona-crisis by Psychologists and Psychiatrists in Home-office and in the Clinic.LetztautorSchaub A et al. Fortschr Neurol Psychiatr 2021. PMID 341266452 Zitationen
  35. Effects of high-frequency prefrontal rTMS on heart frequency rates and blood pressure in schizophrenia.Campana M et al. J Psychiatr Res 2021. PMID 341199094 Zitationen
  36. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.Merritt K et al. JAMA Psychiatry 2021. PMID 33881460124 Zitationen
  37. Differential gene regulation in the anterior cingulate cortex and superior temporal cortex in schizophrenia: A molecular network approach.Gebicke-Haerter PJ et al. Schizophr Res 2021. PMID 340043817 Zitationen
  38. Impact of the COVID-19 pandemic on the care situation in psychiatric hospitals in Germany.LetztautorAdorjan K et al. Nervenarzt 2021. PMID 3400332128 Zitationen
  39. Employment status and desire for work in severe mental illness: results from an observational, cross-sectional study.Gühne U et al. Soc Psychiatry Psychiatr Epidemiol 2021. PMID 3386080447 Zitationen
  40. Association Between Physical Activity and Schizophrenia: Results of a 2-Sample Mendelian Randomization Analysis.LetztautorPapiol S et al. JAMA Psychiatry 2021. PMID 3329594616 Zitationen
  41. Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes.Zuccoli GS et al. Eur Arch Psychiatry Clin Neurosci 2021. PMID 337512077 Zitationen
  42. EPA guidance on treatment of negative symptoms in schizophrenia.Galderisi S et al. Eur Psychiatry 2021. PMID 33726883159 Zitationen
  43. Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.Penzel N et al. Neuropsychopharmacology 2021. PMID 3365865316 Zitationen
  44. Brain Network Simulations Indicate Effects of Neuregulin-1 Genotype on Excitation-Inhibition Balance in Cortical Dynamics.Klein PC et al. Cereb Cortex 2021. PMID 332799679 Zitationen
  45. EPA guidance on assessment of negative symptoms in schizophrenia.Galderisi S et al. Eur Psychiatry 2021. PMID 33597064200 Zitationen
  46. Reduction of bronchial response to mannitol after partial switch from conventional tobacco to electronic cigarette consumption.Rüther T et al. Respir Med 2021. PMID 335719243 Zitationen
  47. Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.Gaigl G et al. Schizophr Res 2021. PMID 3356162019 Zitationen
  48. Role of psychiatric hospitals during a pandemic: introducing the Munich Psychiatric COVID-19 Pandemic Contingency Plan.LetztautorAdorjan K et al. BJPsych Open 2021. PMID 335179409 Zitationen
  49. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.Koutsouleris N et al. JAMA Psychiatry 2021. PMID 33263726201 Zitationen
  50. Dynamics of the immediate behavioral response to partial social exclusion.Dewald-Kaufmann JF et al. Sci Rep 2021. PMID 3347316213 Zitationen
  51. Characteristics and definitions of ultra-treatment-resistant schizophrenia - A systematic review and meta-analysis.Campana M et al. Schizophr Res 2021. PMID 3345464437 Zitationen
  52. Neurogenetics of schizophrenia: findings from studies based on data sharing and global partnerships.LetztautorAdorjan K et al. Nervenarzt 2021. PMID 33439287
  53. Reconceptualising treatment-resistant depression as difficult-to-treat depression.McAllister-Williams RH et al. Lancet Psychiatry 2021. PMID 3334116022 Zitationen
  54. The burden of caring for someone with schizophrenia: A cross country report from Bulgaria, the Czech Republic, Hungary and Russia.LetztautorBarbara S et al. Psychiatr Hung 2021. PMID 349395721 Zitationen
  55. Beitrag ohne Titelangabe in PubMedLetztautorSchiltz K, Falkai P. Fortschr Neurol Psychiatr 2021. PMID 34666390
  56. Beitrag ohne Titelangabe in PubMedErstautorFalkai P, Schmitt A. Fortschr Neurol Psychiatr 2021. PMID 33465810

2020

  1. Acquisition and Use of 'Priors' in Autism: Typical in Deciding Where to Look, Atypical in Deciding What Is There.Allenmark F et al. J Autism Dev Disord 2020. PMID 3337301415 Zitationen
  2. Modeling Obstetric Complications in Schizophrenia.ErstautorFalkai P et al. Biol Psychiatry Cogn Neurosci Neuroimaging 2020. PMID 33288033
  3. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.Wagner E et al. Schizophr Bull 2020. PMID 3242118899 Zitationen
  4. Basic Symptoms Are Associated With Age in Patients With a Clinical High-Risk State for Psychosis: Results From the PRONIA Study.Walger H et al. Front Psychiatry 2020. PMID 3331213312 Zitationen
  5. Care of patients with mental illness and SARS-CoV-2 infection at the Department of Psychiatry and Psychotherapy LMU Munich, Germany.Adorjan K et al. MMW Fortschr Med 2020. PMID 332899132 Zitationen
  6. The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment.Gaebel W et al. Schizophr Res 2020. PMID 332036103 Zitationen
  7. The Generalized Adaptation Account of Autism.Gernert C et al. Front Neurosci 2020. PMID 331229854 Zitationen
  8. Changes in antidepressant therapy should be considered early in patients with inadequate response to a first-line agent.LetztautorBaune BT, Falkai P. Aust N Z J Psychiatry 2020. PMID 331115383 Zitationen
  9. Evaluation of evidence grades in psychiatry and psychotherapy guidelines.Löhrs L et al. BMC Psychiatry 2020. PMID 330460402 Zitationen
  10. Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4.Badowska DM et al. Transl Psychiatry 2020. PMID 3303717821 Zitationen
  11. Psychosocial support during the COVID-19 pandemic: interdisciplinary concept of care at a university hospital.Reinhard MA et al. Nervenarzt 2020. PMID 330250718 Zitationen
  12. Coercive measures and the SARS-CoV-2 pandemic.Adorjan K et al. Nervenarzt 2020. PMID 330012645 Zitationen
  13. The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort study.Gorwood P et al. Hum Psychopharmacol 2020. PMID 329766779 Zitationen
  14. Impact of smoking behavior on clozapine blood levels - a systematic review and meta-analysis.Wagner E et al. Acta Psychiatr Scand 2020. PMID 3286927876 Zitationen
  15. Marathon running improves mood and negative affect.Roeh A et al. J Psychiatr Res 2020. PMID 3285407617 Zitationen
  16. Compulsory admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries.Wasserman D et al. Eur Psychiatry 2020. PMID 3282974049 Zitationen
  17. Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic.Kramer V et al. Eur Arch Psychiatry Clin Neurosci 2020. PMID 3281501991 Zitationen
  18. Effects of Smoking Status on Remission and Metabolic and Cognitive Outcomes in Schizophrenia Patients Treated with Clozapine.Wagner E et al. Pharmacopsychiatry 2020. PMID 327571781 Zitationen
  19. Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial.LetztautorMaurus I et al. Eur Arch Psychiatry Clin Neurosci 2020. PMID 3274826122 Zitationen
  20. Impact of the metabolic syndrome on severe mental disorders.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2020. PMID 325881313 Zitationen
  21. Was King Ludwig II of Bavaria misdiagnosed by Gudden and his colleagues?LetztautorSteinberg R, Falkai P. Eur Arch Psychiatry Clin Neurosci 2020. PMID 326962752 Zitationen
  22. An overview of the human brain myelin proteome and differences associated with schizophrenia.Martins-de-Souza D et al. World J Biol Psychiatry 2020. PMID 3260282412 Zitationen
  23. Schizophrenia.Hasan A et al. Dtsch Arztebl Int 2020. PMID 3286549241 Zitationen
  24. rTMS and tDCS for the treatment of catatonia: A systematic review.Hansbauer M et al. Schizophr Res 2020. PMID 3260077922 Zitationen
  25. Effects of 1 mA and 2 mA transcranial direct current stimulation on working memory performance in healthy participants.Papazova I et al. Conscious Cogn 2020. PMID 3250290816 Zitationen
  26. Traces of Trauma: A Multivariate Pattern Analysis of Childhood Trauma, Brain Structure, and Clinical Phenotypes.Popovic D et al. Biol Psychiatry 2020. PMID 3278213946 Zitationen
  27. 12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment concepts.Kamp F et al. J Psychiatr Res 2020. PMID 326523386 Zitationen
  28. Personality Traits in Marathon Runners and Sedentary Controls With MMPI-2-RF.Roeh A et al. Front Psychol 2020. PMID 324576865 Zitationen
  29. A machine learning approach to risk assessment for alcohol withdrawal syndrome.Burkhardt G et al. Eur Neuropsychopharmacol 2020. PMID 324188434 Zitationen
  30. Digging deeper in the proteome of different regions from schizophrenia brains.Reis-de-Oliveira G et al. J Proteomics 2020. PMID 3238984220 Zitationen
  31. Cognitive and emotional empathy in individuals at clinical high risk of psychosis.Montag C et al. Acta Psychiatr Scand 2020. PMID 3233925420 Zitationen
  32. An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.Dwyer DB et al. JAMA Psychiatry 2020. PMID 3204927453 Zitationen
  33. Glutamatergic Contribution to Probabilistic Reasoning and Jumping to Conclusions in Schizophrenia: A Double-Blind, Randomized Experimental Trial.Strube W et al. Biol Psychiatry 2020. PMID 3251342413 Zitationen
  34. Effect of aerobic exercise on cortical thickness in patients with schizophrenia-A dataset.LetztautorTakahashi S et al. Data Brief 2020. PMID 323955752 Zitationen
  35. Affected neural networks as basis of disturbed motor function in schizophrenia.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2020. PMID 321444971 Zitationen
  36. The impact of endurance training and table soccer on brain metabolites in schizophrenia.LetztautorRauchmann BS et al. Brain Imaging Behav 2020. PMID 316863089 Zitationen
  37. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.Amare AT et al. Mol Psychiatry 2020. PMID 3220315572 Zitationen
  38. Implementation of the patient version of the evidence-based (S3) guideline for psychosocial interventions for patients with severe mental illness (IMPPETUS): study protocol for a cluster randomised controlled trial.Breilmann J et al. Trials 2020. PMID 321838977 Zitationen
  39. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.Endres D et al. Eur Arch Psychiatry Clin Neurosci 2020. PMID 3216650386 Zitationen
  40. Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine.Wagner E et al. World J Biol Psychiatry 2020. PMID 3208107117 Zitationen
  41. Sex Matters: A Multivariate Pattern Analysis of Sex- and Gender-Related Neuroanatomical Differences in Cis- and Transgender Individuals Using Structural Magnetic Resonance Imaging.Baldinger-Melich P et al. Cereb Cortex 2020. PMID 3136848720 Zitationen
  42. The identification, assessment and management of difficult-to-treat depression: An international consensus statement.McAllister-Williams RH et al. J Affect Disord 2020. PMID 32217227219 Zitationen
  43. The role of environmental stress and DNA methylation in the longitudinal course of bipolar disorder.Comes AL et al. Int J Bipolar Disord 2020. PMID 3204812614 Zitationen
  44. The revised German evidence- and consensus-based schizophrenia guideline.Gaebel W et al. World Psychiatry 2020. PMID 3192267530 Zitationen
  45. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.Steiner J et al. Schizophr Bull 2020. PMID 31504969124 Zitationen
  46. Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: A machine learning analysis of the ELECT-TDCS study.Kambeitz J et al. J Affect Disord 2020. PMID 3209077325 Zitationen
  47. Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.LetztautorHasan A et al. Contemp Clin Trials Commun 2020. PMID 3207207116 Zitationen
  48. Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations.Hasan A et al. Nervenarzt 2020. PMID 3160516116 Zitationen
  49. Beitrag ohne Titelangabe in PubMedPopovic D et al. Fortschr Neurol Psychiatr 2020. PMID 333075612 Zitationen
  50. Beitrag ohne Titelangabe in PubMedLetztautorGaebel W, Falkai P. Fortschr Neurol Psychiatr 2020. PMID 33307560

2019

  1. Catatonia in clinical reality: underdiagnosed and forgotten.Adorjan K et al. MMW Fortschr Med 2019. PMID 318286723 Zitationen
  2. Effect of aerobic exercise combined with cognitive remediation on cortical thickness and prediction of social adaptation in patients with schizophrenia.LetztautorTakahashi S et al. Schizophr Res 2019. PMID 3180652227 Zitationen
  3. A Pattern of Cognitive Deficits Stratified for Genetic and Environmental Risk Reliably Classifies Patients With Schizophrenia From Healthy Control Subjects.Antonucci LA et al. Biol Psychiatry 2019. PMID 3194864036 Zitationen
  4. Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction.Raabe FJ et al. Cells 2019. PMID 3177116660 Zitationen
  5. Polygenic burden associated to oligodendrocyte precursor cells and radial glia influences the hippocampal volume changes induced by aerobic exercise in schizophrenia patients.LetztautorPapiol S et al. Transl Psychiatry 2019. PMID 3171261725 Zitationen
  6. Premature mortality, causes of death, and mental disorders.LetztautorAdorjan K, Falkai P. Lancet 2019. PMID 3166872410 Zitationen
  7. Accuracy of diagnostic classification and clinical utility assessment of ICD-11 compared to ICD-10 in 10 mental disorders: findings from a web-based field study.LetztautorGaebel W et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 3165411928 Zitationen
  8. Quantitative Subcellular Proteomics of the Orbitofrontal Cortex of Schizophrenia Patients.Velásquez E et al. J Proteome Res 2019. PMID 3158177623 Zitationen
  9. Multivariate classification of schizophrenia and its familial risk based on load-dependent attentional control brain functional connectivity.Antonucci LA et al. Neuropsychopharmacology 2019. PMID 3158117527 Zitationen
  10. Nonpharmacological treatment of dyscognition in schizophrenia: effects 
of aerobic exercise
.Maurus I et al. Dialogues Clin Neurosci 2019. PMID 317496506 Zitationen
  11. Resistance training in patients with schizophrenia: Concept and proof of principle trial.Maurus I et al. J Psychiatr Res 2019. PMID 3163475210 Zitationen
  12. Association between altered hippocampal oligodendrocyte number and neuronal circuit structures in schizophrenia: a postmortem analysis.ErstautorFalkai P et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 3155249510 Zitationen
  13. Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT.Gaebel W et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 3152014911 Zitationen
  14. The genetic relationship between educational attainment and cognitive performance in major psychiatric disorders.Comes AL et al. Transl Psychiatry 2019. PMID 3146263029 Zitationen
  15. Aerobic exercise in mental disorders: from basic mechanisms to treatment recommendations.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 312500879 Zitationen
  16. Running effects on cognition and plasticity (ReCaP): study protocol of a longitudinal examination of multimodal adaptations of marathon running.Roeh A et al. Res Sports Med 2019. PMID 3134507312 Zitationen
  17. A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 3107683829 Zitationen
  18. The need to develop personalized interventions to improve cognition in schizophrenia.ErstautorFalkai P, Schmitt A. World Psychiatry 2019. PMID 3105961923 Zitationen
  19. Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia.Trossbach SV et al. Transl Psychiatry 2019. PMID 3115001322 Zitationen
  20. Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia.LetztautorMaurus I et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 3111566052 Zitationen
  21. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.Proebstl L et al. Eur Psychiatry 2019. PMID 3098174641 Zitationen
  22. Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives.LetztautorPopovic D et al. Front Neurosci 2019. PMID 30983960125 Zitationen
  23. Depression in Somatic Disorders: Is There a Beneficial Effect of Exercise?Roeh A et al. Front Psychiatry 2019. PMID 3094907919 Zitationen
  24. The Influence of Continuous Exercising on Chronotropic Incompetence in Multi-Episode Schizophrenia.Herbsleb M et al. Front Psychiatry 2019. PMID 309184869 Zitationen
  25. The BDNFSNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.Franzmeier N et al. Mol Psychiatry 2019. PMID 3089909264 Zitationen
  26. When exhaustion becomes a torment - from excessive labour to burn-out.LetztautorPalm U, Falkai P. MMW Fortschr Med 2019. PMID 30887328
  27. The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial.Peterson DL et al. Schizophr Res 2019. PMID 3079921815 Zitationen
  28. Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model.Böge K et al. Eur Arch Psychiatry Clin Neurosci 2019. PMID 3079652833 Zitationen
  29. WFSBP guidelines on how to grade treatment evidence for clinical guideline development.Hasan A et al. World J Biol Psychiatry 2019. PMID 3052618234 Zitationen
  30. Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.Wagner E et al. Schizophr Res 2019. PMID 3070486217 Zitationen
  31. Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance.Wagner E et al. J Psychopharmacol 2019. PMID 3069633260 Zitationen
  32. The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.Anderson-Schmidt H et al. Schizophr Res 2019. PMID 306116559 Zitationen
  33. Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment.LetztautorSteiner J et al. World J Biol Psychiatry 2019. PMID 3051325346 Zitationen

2018

  1. Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality.LetztautorSchmitt A et al. Front Psychiatry 2018. PMID 3062248665 Zitationen
  2. Predicting instructed simulation and dissimulation when screening for depressive symptoms.Goerigk S et al. Eur Arch Psychiatry Clin Neurosci 2018. PMID 305428185 Zitationen
  3. Prospective acceptance of distinct mobile mental health features in psychiatric patients and mental health professionals.Hendrikoff L et al. J Psychiatr Res 2018. PMID 3053020724 Zitationen
  4. Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.Kambeitz-Ilankovic L et al. Neuroimage Clin 2018. PMID 305289609 Zitationen
  5. Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.Kirchner SK et al. Eur Arch Psychiatry Clin Neurosci 2018. PMID 305234044 Zitationen
  6. Impaired recovery in affective disorders and schizophrenia: sharing a common pathophysiology?ErstautorFalkai P et al. Eur Arch Psychiatry Clin Neurosci 2018. PMID 303747041 Zitationen
  7. Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder.Budde M et al. Eur Neuropsychopharmacol 2018. PMID 305037839 Zitationen
  8. Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study.Hooshmand B et al. Am J Med 2018. PMID 3050231629 Zitationen
  9. Self-esteem fully mediates positive life events and depressive symptoms in a sample of 173 patients with affective disorders.Sarubin N et al. Psychol Psychother 2018. PMID 304885398 Zitationen
  10. Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems.Raabe FJ et al. NPJ Schizophr 2018. PMID 3045185032 Zitationen
  11. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.Koutsouleris N et al. JAMA Psychiatry 2018. PMID 30267047279 Zitationen
  12. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH).Stubbs B et al. Eur Psychiatry 2018. PMID 30257806449 Zitationen
  13. Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.Kamp D et al. Schizophr Res 2018. PMID 302494717 Zitationen
  14. The crying patient.Winter J et al. MMW Fortschr Med 2018. PMID 30206847
  15. The speechless patient.Häckert J et al. MMW Fortschr Med 2018. PMID 30206846
  16. Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.Stübner S et al. Int J Neuropsychopharmacol 2018. PMID 2993926436 Zitationen
  17. Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.Kamp F et al. Neuropsychopharmacology 2018. PMID 3018851233 Zitationen
  18. A longitudinal approach to biological psychiatric research: The PsyCourse study.Budde M et al. Am J Med Genet B Neuropsychiatr Genet 2018. PMID 3007005761 Zitationen
  19. Psychiatry and psychiatrists: Fourteen core statements.LetztautorGalderisi S, Falkai P. Eur Psychiatry 2018. PMID 299146731 Zitationen
  20. Brain Subtyping Enhances The Neuroanatomical Discrimination of Schizophrenia.Dwyer DB et al. Schizophr Bull 2018. PMID 2952927086 Zitationen
  21. Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis.Koutsouleris N et al. Schizophr Bull 2018. PMID 2898187561 Zitationen
  22. Effects of Three Months of Aerobic Endurance Training on Motor Cortical Excitability in Schizophrenia Patients and Healthy Subjects.Malchow B et al. Neuropsychobiology 2018. PMID 300015388 Zitationen
  23. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM.Oviedo-Salcedo T et al. Br J Psychiatry 2018. PMID 299867722 Zitationen
  24. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.Kalman JL et al. Bipolar Disord 2018. PMID 2995643627 Zitationen
  25. Improving working memory in schizophrenia: Effects of 1 mA and 2 mA transcranial direct current stimulation to the left DLPFC.Papazova I et al. Schizophr Res 2018. PMID 2995470135 Zitationen
  26. Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.Reinbold CS et al. Front Psychiatry 2018. PMID 2990435925 Zitationen
  27. Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach.LetztautorSteiner J et al. Nervenarzt 2018. PMID 2952391311 Zitationen
  28. The Role of Self-Esteem in Depression: A Longitudinal Study.Hilbert S et al. Behav Cogn Psychother 2018. PMID 2969227824 Zitationen
  29. Web-based field studies on diagnostic classification and code assignment of mental disorders: comparison of ICD-11 and ICD-10.LetztautorGaebel W et al. Fortschr Neurol Psychiatr 2018. PMID 296218227 Zitationen
  30. Beginning of a new series: psychiatry and neurology based issues.ErstautorFalkai P, Gaebel W. Fortschr Neurol Psychiatr 2018. PMID 29621816
  31. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.Franzmeier N et al. Brain 2018. PMID 2946233494 Zitationen
  32. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders.Oviedo-Salcedo T et al. Br J Psychiatry 2018. PMID 2958789534 Zitationen
  33. Reply to: Sample Size, Model Robustness, and Classification Accuracy in Diagnostic Multivariate Neuroimaging Analyses.Kambeitz J et al. Biol Psychiatry 2018. PMID 295805722 Zitationen
  34. Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age.Ramos-Miguel A et al. Neurobiol Dis 2018. PMID 2949654434 Zitationen
  35. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.Hansbauer M et al. Psychiatry Res 2018. PMID 2948204215 Zitationen
  36. Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats.von Wilmsdorff M et al. Eur Arch Psychiatry Clin Neurosci 2018. PMID 294046868 Zitationen
  37. Machine Learning Approaches for Clinical Psychology and Psychiatry.Dwyer DB et al. Annu Rev Clin Psychol 2018. PMID 29401044577 Zitationen
  38. Effects of exercise-based interventions in severe mental illness: a feasibility study.LetztautorOgunyankin F et al. Eur Arch Psychiatry Clin Neurosci 2018. PMID 293502652 Zitationen
  39. Pioneering research developments in psychiatry.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2018. PMID 29342481
  40. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. et al. JAMA Psychiatry 2018. PMID 29121268151 Zitationen
  41. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. MMW Fortschr Med 2018. PMID 30206850

2017

  1. Commentary on "Systems Neuroscience of Psychosis (SyNoPsis): Mapping Schizophrenia Symptoms onto Brain Systems".AlleinautorFalkai P. Neuropsychobiology 2017. PMID 292581181 Zitationen
  2. On the search of new treatment strategies in patients with affective disorders.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2017. PMID 29071371
  3. An effective treatment concept for patients with substance use disorders.Adorjan K et al. MMW Fortschr Med 2017. PMID 29557094
  4. Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.Jobst A et al. J Affect Disord 2017. PMID 2910015422 Zitationen
  5. Synaptosomal Proteome of the Orbitofrontal Cortex from Schizophrenia Patients Using Quantitative Label-Free and iTRAQ-Based Shotgun Proteomics.Velásquez E et al. J Proteome Res 2017. PMID 2894914629 Zitationen
  6. Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice.Wehr MC et al. EMBO Mol Med 2017. PMID 2874378437 Zitationen
  7. Practicals in a psychiatric clinic for occupational orientation in pupils.LetztautorSchaub A et al. Fortschr Neurol Psychiatr 2017. PMID 28881361
  8. Is the theoretical support for the improvement of brain plasiticity in schizophrenic psychoses adequate?.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2017. PMID 28881360
  9. Healthcare models for traumatized refugees in Germany.Adorjan K et al. Nervenarzt 2017. PMID 286429828 Zitationen
  10. Mental health as a global challenge : Research, care and participation.Deister A et al. Nervenarzt 2017. PMID 28642981
  11. Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.Müller S et al. Sci Rep 2017. PMID 2884255934 Zitationen
  12. Effectiveness and cost-effectiveness of an integrated care program for schizophrenia: an analysis of routine data.Kerkemeyer L et al. Eur Arch Psychiatry Clin Neurosci 2017. PMID 287914851 Zitationen
  13. Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia.Agís-Balboa RC et al. EMBO J 2017. PMID 2876871737 Zitationen
  14. A systematic review of trials investigating strength training in schizophrenia spectrum disorders.Keller-Varady K et al. Schizophr Res 2017. PMID 2860264823 Zitationen
  15. DGPPN recommendations on quality indicators for schizophrenia.Großimlinghaus I et al. Nervenarzt 2017. PMID 284848226 Zitationen
  16. Coercive measures in German hospitals for psychiatry and psychotherapy : A pilot study by the DGPPN to evaluate a uniform assessment instrument.Adorjan K et al. Nervenarzt 2017. PMID 2798137521 Zitationen
  17. The Nuclear Proteome of White and Gray Matter from Schizophrenia Postmortem Brains.Saia-Cereda VM et al. Mol Neuropsychiatry 2017. PMID 2887920022 Zitationen
  18. Polygenic risk has an impact on the structural plasticity of hippocampal subfields during aerobic exercise combined with cognitive remediation in multi-episode schizophrenia.Papiol S et al. Transl Psychiatry 2017. PMID 2865409535 Zitationen
  19. Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia.Kamp D et al. Schizophr Res 2017. PMID 2857892410 Zitationen
  20. HDAC1 links early life stress to schizophrenia-like phenotypes.Bahari-Javan S et al. Proc Natl Acad Sci U S A 2017. PMID 2853341874 Zitationen
  21. The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.Goff DC et al. Am J Psychiatry 2017. PMID 28472900144 Zitationen
  22. Aerobic exercise and its effects on cognition in schizophrenia.ErstautorFalkai P et al. Curr Opin Psychiatry 2017. PMID 2823063139 Zitationen
  23. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.van Kesteren CF et al. Transl Psychiatry 2017. PMID 28350400294 Zitationen
  24. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample.Ramos-Miguel A et al. Mol Neurodegener 2017. PMID 2832044119 Zitationen
  25. Aerobic exercise in major psychiatric disorders: promises and challenges.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2017. PMID 281618033 Zitationen
  26. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care.Hasan A et al. Int J Psychiatry Clin Pract 2017. PMID 2849809076 Zitationen
  27. Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC).Padberg F et al. Eur Arch Psychiatry Clin Neurosci 2017. PMID 2824689135 Zitationen
  28. Unmet Needs in Schizophrenia.Pompili M et al. CNS Neurol Disord Drug Targets 2017. PMID 2878249019 Zitationen
  29. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. Drug Res (Stuttg) 2017. PMID 290696712 Zitationen
  30. Beitrag ohne Titelangabe in PubMedErstautorFalkai P, Endres S. Drug Res (Stuttg) 2017. PMID 29069670

2016

  1. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.Howes OD et al. Am J Psychiatry 2016. PMID 27919182895 Zitationen
  2. Detecting Neuroimaging Biomarkers for Depression: A Meta-analysis of Multivariate Pattern Recognition Studies.Kambeitz J et al. Biol Psychiatry 2016. PMID 28110823114 Zitationen
  3. Vagus nerve stimulation in psychiatry: a systematic review of the available evidence.Cimpianu CL et al. J Neural Transm (Vienna) 2016. PMID 2784803493 Zitationen
  4. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.LetztautorSchmitt A et al. World J Biol Psychiatry 2016. PMID 2778276728 Zitationen
  5. Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia.Hasan A et al. Mol Psychiatry 2016. PMID 2772565543 Zitationen
  6. Stepping up: the just released new impact factor 2015.LetztautorReich-Erkelenz D et al. Eur Arch Psychiatry Clin Neurosci 2016. PMID 274305051 Zitationen
  7. Psychosis - clinical differential diagnosis.Röh A et al. Fortschr Neurol Psychiatr 2016. PMID 275709082 Zitationen
  8. Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach.Koutsouleris N et al. Lancet Psychiatry 2016. PMID 27569526162 Zitationen
  9. Bidirectional variability in motor cortex excitability modulation following 1 mA transcranial direct current stimulation in healthy participants.Strube W et al. Physiol Rep 2016. PMID 2749529861 Zitationen
  10. Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications.LetztautorMöller HJ et al. Eur Arch Psychiatry Clin Neurosci 2016. PMID 272164336 Zitationen
  11. Psychoeducational and Cognitive Behavioral Treatment Programs: Implementation and Evaluation From 1995 to 2015 in Kraepelin's Former Hospital.LetztautorSchaub A et al. Schizophr Bull 2016. PMID 274606215 Zitationen
  12. A Randomized Controlled Trial of Group Coping-Oriented Therapy vs Supportive Therapy in Schizophrenia: Results of a 2-Year Follow-up.LetztautorSchaub A et al. Schizophr Bull 2016. PMID 2746062018 Zitationen
  13. Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study.ErstautorFalkai P et al. Schizophr Bull 2016. PMID 2746061775 Zitationen
  14. Aberrant Functional Whole-Brain Network Architecture in Patients With Schizophrenia: A Meta-analysis.Kambeitz J et al. Schizophr Bull 2016. PMID 2746061594 Zitationen
  15. Classifying Schizophrenia Using Multimodal Multivariate Pattern Recognition Analysis: Evaluating the Impact of Individual Clinical Profiles on the Neurodiagnostic Performance.Cabral C et al. Schizophr Bull 2016. PMID 2746061469 Zitationen
  16. Special Supplement Introduction: The Fourth Kraepelin Symposium-Cognitive Dysfunction in Schizophrenia: Origins and Innovative Treatment.LetztautorSchaub A, Falkai P. Schizophr Bull 2016. PMID 274606131 Zitationen
  17. Treatment-resistant Schizophrenia and Global Cortical Atrophy in a Patient with Turner Syndrome.Langgartner S et al. Pharmacopsychiatry 2016. PMID 274587423 Zitationen
  18. Shall we really say goodbye to first rank symptoms?Heinz A et al. Eur Psychiatry 2016. PMID 2742916729 Zitationen
  19. News from the graveyard: Neuropathological research on schizophrenia is alive and productive.ErstautorFalkai P, Schmitt A. Schizophr Res 2016. PMID 273722551 Zitationen
  20. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.Hou L et al. Hum Mol Genet 2016. PMID 27329760156 Zitationen
  21. Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients.Café-Mendes CC et al. J Proteomics 2016. PMID 2732191419 Zitationen
  22. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.LetztautorSchmitt A et al. World J Biol Psychiatry 2016. PMID 2731198728 Zitationen
  23. Erratum to: EPA guidance on improving the image of psychiatry.LetztautorMöller-Leimkühler AM et al. Eur Arch Psychiatry Clin Neurosci 2016. PMID 270941913 Zitationen
  24. Neurobiological background of borderline personality disorder, PTSD and ADHD.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2016. PMID 268946591 Zitationen
  25. Corrigendum to "Investigations of motor-cortex cortical plasticity following facilitatory and inhibitory transcranial theta-burst stimulation in schizophrenia: A proof-of-concept study" [J. Psychiatr. Res. 61 (2015 Feb) 196-204].Hasan A et al. J Psychiatr Res 2016. PMID 27499423
  26. Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.Seemüller F et al. BMC Psychiatry 2016. PMID 2720663413 Zitationen
  27. Differential response to anodal tDCS and PAS is indicative of impaired focal LTP-like plasticity in schizophrenia.Strube W et al. Behav Brain Res 2016. PMID 2718573817 Zitationen
  28. Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study.Uhrig S et al. Schizophr Res 2016. PMID 2713249462 Zitationen
  29. Nicotine-dopamine-transporter interactions during reward-based decision making.Kambeitz J et al. Eur Neuropsychopharmacol 2016. PMID 271129684 Zitationen
  30. Prefrontal Transcranial Direct Current Stimulation for Treatment of Schizophrenia With Predominant Negative Symptoms: A Double-Blind, Sham-Controlled Proof-of-Concept Study.Palm U et al. Schizophr Bull 2016. PMID 27098066108 Zitationen
  31. Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients.Saia-Cereda VM et al. Schizophr Res 2016. PMID 2709472028 Zitationen
  32. Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits.ErstautorFalkai P et al. Front Cell Neurosci 2016. PMID 2706580444 Zitationen
  33. Lower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations.Jobst A et al. Front Hum Neurosci 2016. PMID 2706469658 Zitationen
  34. Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia.Barakauskas VE et al. Schizophr Res 2016. PMID 2697107217 Zitationen
  35. The 26th Danube Symposium of Psychiatry: Psychiatry - ready for the future?LetztautorPalm U et al. Psychiatr Danub 2016. PMID 26938830
  36. Guideline-conform psychiatric psychotherapeutic treatment for patients with schizophrenia : A normative evaluation of necessary personnel requirements.Mehl S et al. Nervenarzt 2016. PMID 268204577 Zitationen
  37. EPA guidance on improving the image of psychiatry.LetztautorMöller-Leimkühler AM et al. Eur Arch Psychiatry Clin Neurosci 2016. PMID 2687495922 Zitationen
  38. European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe.Jobst A et al. Eur Psychiatry 2016. PMID 2685498498 Zitationen
  39. Morphological and functional alterations in patients with schizophrenia spectrum disorders.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2016. PMID 266506875 Zitationen
  40. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.Hou L et al. Lancet 2016. PMID 26806518274 Zitationen
  41. The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects.Heilbronner U et al. Harv Rev Psychiatry 2016. PMID 26954596134 Zitationen
  42. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. Fortschr Neurol Psychiatr 2016. PMID 27846650
  43. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. Fortschr Neurol Psychiatr 2016. PMID 27100843

2015

  1. Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment.Brzózka MM et al. Schizophr Bull 2015. PMID 267147649 Zitationen
  2. Focussing on the Individual--Opportunities for a Personalised Psychiatry and Psychotherapy.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2015. PMID 26633838
  3. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample.Ramos-Miguel A et al. Mol Neurodegener 2015. PMID 2662800345 Zitationen
  4. Unravelling basic mechanisms in addiction and neuropsychiatric disorders.LetztautorReich-Erkelenz D et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 26459020
  5. Non-invasive brain stimulation for treatment of schizophrenic psychoses.Hasan A et al. Nervenarzt 2015. PMID 263416905 Zitationen
  6. Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.Gaebel W et al. Schizophr Res 2015. PMID 2660710228 Zitationen
  7. Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia.Vendramini PH et al. Schizophr Res 2015. PMID 2654529610 Zitationen
  8. Endurance training in patients with schizophrenia and healthy controls: differences and similarities.Keller-Varady K et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 2654183523 Zitationen
  9. Treatment pathways in the care of patients with schizophrenia and depression.Salize HJ et al. Nervenarzt 2015. PMID 263841062 Zitationen
  10. Assessment of quality indicators with routine data: Presentation of a feasibility test in ten specialist clinics for psychiatry and psychotherapy.Großimlinghaus I et al. Nervenarzt 2015. PMID 2612263913 Zitationen
  11. Work on the stress axis brings relief. Helping the highly sensitive patient.ErstautorFalkai P, Starostzik C. MMW Fortschr Med 2015. PMID 26985476
  12. A common risk variant in CACNA1C supports a sex-dependent effect on longitudinal functioning and functional recovery from episodes of schizophrenia-spectrum but not bipolar disorder.Heilbronner U et al. Eur Neuropsychopharmacol 2015. PMID 2647557512 Zitationen
  13. Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial.Hasan A et al. Schizophr Bull 2015. PMID 2643321773 Zitationen
  14. Negative symptoms and therapy strategies in schizophrenia.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2015. PMID 26319528
  15. Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.Cassoli JS et al. NPJ Schizophr 2015. PMID 2733604069 Zitationen
  16. Genetic and environmental risk factors in neurodevelopmental disorders.LetztautorReich-Erkelenz D et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 262052512 Zitationen
  17. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.Saia-Cereda VM et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 2623207753 Zitationen
  18. Erythropoietin as an Innovative Add-on Therapy for Depression.ErstautorFalkai P, Schmitt A. Biol Psychiatry 2015. PMID 261951762 Zitationen
  19. DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2015. PMID 26021299
  20. Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study.Hasan A et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 2621030357 Zitationen
  21. Risk Factors for Depression an Anxiety Disorders and Use of Light Therapy.ErstautorFalkai P, Schmitt A. Fortschr Neurol Psychiatr 2015. PMID 26098080
  22. Classification and neurobiological concepts of mania, bipolar disorder and major depression.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2015. PMID 259004694 Zitationen
  23. Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.Koutsouleris N et al. Brain 2015. PMID 25935725117 Zitationen
  24. Resource use and financing of guideline-adherent psychotherapeutic inpatient care.Normann C et al. Nervenarzt 2015. PMID 2587704211 Zitationen
  25. Depressive symptoms in schizophrenia.Grüber L et al. Fortschr Neurol Psychiatr 2015. PMID 258934975 Zitationen
  26. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation.Hasan A et al. World J Biol Psychiatry 2015. PMID 2582280490 Zitationen
  27. Psychiatrists' self-stigma, the DGPPN guideline for psychosocial interventions, and contemporary treatment strategies.LetztautorReich-Erkelenz D et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 257084573 Zitationen
  28. First results of a refeeding program in a psychiatric intensive care unit for patients with extreme anorexia nervosa.Born C et al. BMC Psychiatry 2015. PMID 2588469721 Zitationen
  29. Kraepelin revisited: schizophrenia from degeneration to failed regeneration.ErstautorFalkai P et al. Mol Psychiatry 2015. PMID 2582430364 Zitationen
  30. Prediction of outcome in the psychosis prodrome using neuroanatomical pattern classification.Kambeitz-Ilankovic L et al. Schizophr Res 2015. PMID 2581993642 Zitationen
  31. Family load impacts orbitofrontal volume in first-episode schizophrenia.Malchow B et al. Psychiatry Res 2015. PMID 258002181 Zitationen
  32. Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients.LetztautorMalchow B et al. Schizophr Bull 2015. PMID 2578277082 Zitationen
  33. Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations?Gade K et al. World J Biol Psychiatry 2015. PMID 2577193615 Zitationen
  34. Schizophrenia spectrum and related neuropathology.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2015. PMID 256264441 Zitationen
  35. Neurobiology of schizophrenia: new findings from the structure to the molecules.Schmitt A et al. Nervenarzt 2015. PMID 251233665 Zitationen
  36. EPA guidance on the role and responsibilities of psychiatrists.Bhugra D et al. Eur Psychiatry 2015. PMID 2573580825 Zitationen
  37. Pathways to personalized treatment strategies for depressive disorders.LetztautorBadowska DM et al. Eur Arch Psychiatry Clin Neurosci 2015. PMID 255286481 Zitationen
  38. Effects of endurance training on brain structures in chronic schizophrenia patients and healthy controls.LetztautorMalchow B et al. Schizophr Res 2015. PMID 2562360164 Zitationen
  39. Detecting neuroimaging biomarkers for schizophrenia: a meta-analysis of multivariate pattern recognition studies.Kambeitz J et al. Neuropsychopharmacology 2015. PMID 25601228163 Zitationen
  40. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology.LetztautorThibaut F et al. World J Biol Psychiatry 2015. PMID 2621311133 Zitationen
  41. Beitrag ohne Titelangabe in PubMedAlleinautorFalkai P. Fortschr Neurol Psychiatr 2015. PMID 26588722

2014

  1. Investigations of motor-cortex cortical plasticity following facilitatory and inhibitory transcranial theta-burst stimulation in schizophrenia: a proof-of-concept study.Hasan A et al. J Psychiatr Res 2014. PMID 2555530414 Zitationen
  2. New aspects of cognition domains and psychopathological measures in psychiatry.LetztautorReich-Erkelenz D et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 25331428
  3. Confusion states. The schizophrenia spectrum is unexpectedly large.LetztautorHasan A et al. MMW Fortschr Med 2014. PMID 25543361
  4. Effects of social exclusion on emotions and oxytocin and cortisol levels in patients with chronic depression.Jobst A et al. J Psychiatr Res 2014. PMID 2546683362 Zitationen
  5. The challenges of demographic change - mental illnesses today and tomorrow.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2014. PMID 25383927
  6. Selected issues of the DGPPN Congress in 2013.Maier W et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 25248997
  7. BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.Strube W et al. Int J Neuropsychopharmacol 2014. PMID 2561289628 Zitationen
  8. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial.Wobrock T et al. Biol Psychiatry 2014. PMID 25582269120 Zitationen
  9. Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study.Strube W et al. Neuropsychopharmacology 2014. PMID 2530835122 Zitationen
  10. Stereological investigation of the posterior hippocampus in affective disorders.Malchow B et al. J Neural Transm (Vienna) 2014. PMID 2530786924 Zitationen
  11. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.Yu D et al. Am J Psychiatry 2014. PMID 25158072102 Zitationen
  12. Suicide ideation, stability of symptoms and effects of aerobic exercise in major depression.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2014. PMID 251511821 Zitationen
  13. Ability to work and mental disorders].LetztautorAdorjan K et al. MMW Fortschr Med 2014. PMID 252829361 Zitationen
  14. Connectivity and cognition in neuropsychiatric disorders with special emphasis on Alzheimer's disease and Chorea Huntington.LetztautorBadowska D et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 24981135
  15. Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.Durrenberger PF et al. J Neural Transm (Vienna) 2014. PMID 25119539117 Zitationen
  16. Disturbed cortico-amygdalar functional connectivity as pathophysiological correlate of working memory deficits in bipolar affective disorder.Stegmayer K et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 2511914517 Zitationen
  17. The glutamate hypothesis of schizophrenia.Hasan A et al. Fortschr Neurol Psychiatr 2014. PMID 251054315 Zitationen
  18. Historical aspects of Mozart's mental health and diagnostic insights of ADHD and personality disorders.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2014. PMID 248806381 Zitationen
  19. Massive, previously undetected cancer metastasis revealed by application of a depot antipsychotic: a case report.Haeckert J et al. J Clin Psychiatry 2014. PMID 25093486
  20. Indicators of patient care in Psychiatric and Psychosomatic Facilities (VIPP project)--a database project.Wolff-Menzler C et al. Fortschr Neurol Psychiatr 2014. PMID 2501420213 Zitationen
  21. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study.McGrath LM et al. J Am Acad Child Adolesc Psychiatry 2014. PMID 25062598115 Zitationen
  22. The confused patient.Hertel N et al. MMW Fortschr Med 2014. PMID 25022098
  23. Social exclusion leads to divergent changes of oxytocin levels in borderline patients and healthy subjects.Jobst A et al. Psychother Psychosom 2014. PMID 2496903044 Zitationen
  24. Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia.Kittel-Schneider S et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 2495849414 Zitationen
  25. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers.Koutsouleris N et al. Schizophr Bull 2014. PMID 24914177113 Zitationen
  26. Evaluation of an integrated care program for schizophrenia: concept and study design.Kerkemeyer L et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 249069738 Zitationen
  27. The neuropathology of schizophrenia: new insights from postmortem studies.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2014. PMID 247964332 Zitationen
  28. Do manual and voxel-based morphometry measure the same? A proof of concept study.Focke NK et al. Front Psychiatry 2014. PMID 2478279017 Zitationen
  29. From pathophysiology to the development of guidelines and new therapeutic strategies in schizophrenia.ErstautorFalkai P et al. Fortschr Neurol Psychiatr 2014. PMID 247106741 Zitationen
  30. Reward, memory and prediction of treatment response in affective disorders.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2014. PMID 24609835
  31. Improvement of cognitive deficits in the focus of new treatment strategies in schizophrenia.ErstautorFalkai P, Schmitt A. Fortschr Neurol Psychiatr 2014. PMID 24615582
  32. Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors.Seemüller F et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 2459025728 Zitationen
  33. The new risk variant CACNA1C and brain circuits in schizophrenia.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2014. PMID 244819591 Zitationen
  34. The impact of environmental factors in severe psychiatric disorders.LetztautorSchmitt A et al. Front Neurosci 2014. PMID 24574956234 Zitationen
  35. Disturbed anterior prefrontal control of the mesolimbic reward system and increased impulsivity in bipolar disorder.Trost S et al. Neuropsychopharmacology 2014. PMID 2453510157 Zitationen
  36. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.Strube W et al. Behav Brain Res 2014. PMID 2450924820 Zitationen
  37. S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum.Steiner J et al. Eur Arch Psychiatry Clin Neurosci 2014. PMID 2450453116 Zitationen
  38. European Psychiatric Association (EPA) guidance on post-graduate psychiatric training in Europe.Mayer S et al. Eur Psychiatry 2014. PMID 2450324518 Zitationen
  39. Comorbidity, stigma and emotional perception in psychiatric disorders.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2014. PMID 243709973 Zitationen
  40. Physical activity in mental disorders.LetztautorMalchow B et al. MMW Fortschr Med 2014. PMID 249303082 Zitationen
  41. Lifestyle changes body and mind.ErstautorFalkai P, Schmitt A. MMW Fortschr Med 2014. PMID 24930306

2013

  1. Motor cortical excitability assessed by transcranial magnetic stimulation in psychiatric disorders: a systematic review.Bunse T et al. Brain Stimul 2013. PMID 24472621107 Zitationen
  2. Therapeutic targets in major psychiatric disorders revisited.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 241628003 Zitationen
  3. Gene expression in superior temporal cortex of schizophrenia patients.Sellmann C et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 2428773119 Zitationen
  4. Personalised medicine in psychiatry and psychotherapy. A review of the current state-of-the-art in the biomarker-based early recognition of psychoses.Koutsouleris N et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013. PMID 241700814 Zitationen
  5. The human oligodendrocyte proteome.Iwata K et al. Proteomics 2013. PMID 2416709025 Zitationen
  6. Psychiatric psychotherapeutic research in Germany: taking stock and international comparison.ErstautorFalkai P et al. Nervenarzt 2013. PMID 241660172 Zitationen
  7. Selected topics of the DGPPN Congress 2012.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 24091602
  8. National and international schizophrenia guidelines. Update 2013 regarding recommendations about antipsychotic pharmacotherapy.LetztautorHasan A et al. Nervenarzt 2013. PMID 240779695 Zitationen
  9. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture.Davis LK et al. PLoS Genet 2013. PMID 24204291200 Zitationen
  10. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders.Koutsouleris N et al. Schizophr Bull 2013. PMID 24126515368 Zitationen
  11. Impairments of motor-cortex responses to unilateral and bilateral direct current stimulation in schizophrenia.Hasan A et al. Front Psychiatry 2013. PMID 2410945718 Zitationen
  12. Psychiatry caught between emergency response and therapy: compulsory treatment following the jurisprudence of the federal constitutional court and the federal supreme court.Müller JL et al. Psychiatr Prax 2013. PMID 241011376 Zitationen
  13. Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia.Malchow B et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 2408561028 Zitationen
  14. Brain imaging to be on track for improving diagnosis and pathophysiological insights in neuropsychiatric diseases.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 239900801 Zitationen
  15. Common and disease-specific dysfunctions of brain systems underlying attentional and executive control in schizophrenia and bipolar disorder.Melcher T et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 2406160712 Zitationen
  16. Impact of lifestyle in severe psychiatric disorders and brain morphology.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 238927711 Zitationen
  17. Surveillance in the group of schizophrenia: key to understanding the etiology.ErstautorFalkai P, Schmitt A. Nervenarzt 2013. PMID 236577321 Zitationen
  18. Characterization of SLITRK1 variation in obsessive-compulsive disorder.Ozomaro U et al. PLoS One 2013. PMID 2399090234 Zitationen
  19. 5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option.Lennertz L et al. Eur Neuropsychopharmacol 2013. PMID 2392829421 Zitationen
  20. The glutamate system as a therapeutic target and impact of genes on suicidality.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 23818152
  21. CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia.Wolf C et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 2388095928 Zitationen
  22. The effects of physical exercise in schizophrenia and affective disorders.LetztautorMalchow B et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 2387309074 Zitationen
  23. Investigation of the influence of environmental factors in severe psychiatric diseases: epigenetics as new research tool.ErstautorFalkai P, Schmitt A. Fortschr Neurol Psychiatr 2013. PMID 238569411 Zitationen
  24. Lump sum payment system in psychiatry and psychosomatics: concomitant research - quo vadis?.Godemann F et al. Nervenarzt 2013. PMID 2369500510 Zitationen
  25. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.Manchia M et al. PLoS One 2013. PMID 23840348157 Zitationen
  26. Joint crisis plans and psychiatric advance directives in German psychiatric practice.Radenbach K et al. J Med Ethics 2013. PMID 2379305817 Zitationen
  27. Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer's disease.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 23632903
  28. Brain development before onset of the first psychotic episode and during outcome of schizophrenia.ErstautorFalkai P et al. Fortschr Neurol Psychiatr 2013. PMID 236957902 Zitationen
  29. Proteomic similarities between heterozygous reeler mice and schizophrenia.Schmitt A et al. Biol Psychiatry 2013. PMID 236843837 Zitationen
  30. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.Lennertz L et al. Int J Neuropsychopharmacol 2013. PMID 236801037 Zitationen
  31. Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.Gaebel W et al. Schizophr Res 2013. PMID 2364332727 Zitationen
  32. Pattern and volume of the anterior cingulate cortex in chronic posttraumatic stress disorder (PTSD).Jatzko A et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 236130007 Zitationen
  33. The White man's burden - a case study caught between bipolar affective disorder and Huntington's disease.Nowidi K et al. Fortschr Neurol Psychiatr 2013. PMID 23612984
  34. Circadian rhythms investigated on the cellular and molecular levels.LetztautorGebicke-Haerter PJ et al. Pharmacopsychiatry 2013. PMID 235992424 Zitationen
  35. The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients.Anderson-Schmidt H et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 2354594120 Zitationen
  36. Risk genes, metabolic syndrome and eye tracking deficits in psychiatric diseases.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 234556353 Zitationen
  37. Impaired motor cortex responses in non-psychotic first-degree relatives of schizophrenia patients: a cathodal tDCS pilot study.Hasan A et al. Brain Stimul 2013. PMID 2354547322 Zitationen
  38. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.Wobrock T et al. Schizophr Res 2013. PMID 2353747744 Zitationen
  39. Transcranial random noise stimulation for the treatment of negative symptoms in schizophrenia.Palm U et al. Schizophr Res 2013. PMID 2351766429 Zitationen
  40. Developmental process of DGPPN quality indicators.Großimlinghaus I et al. Nervenarzt 2013. PMID 2349424626 Zitationen
  41. Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.Hashimoto K et al. Eur Arch Psychiatry Clin Neurosci 2013. PMID 23455590182 Zitationen
  42. Differential diagnosis of major depression and bipolar disorder.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 233615782 Zitationen
  43. The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline.Pfennig A et al. Dtsch Arztebl Int 2013. PMID 2345100131 Zitationen
  44. Schizophrenia: brain morphology and treatment aspects.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2013. PMID 233063792 Zitationen
  45. A similar but distinctive pattern of impaired cortical excitability in first-episode schizophrenia and ADHD.Hasan A et al. Neuropsychobiology 2013. PMID 2329589314 Zitationen
  46. Transcranial brain stimulation in schizophrenia: targeting cortical excitability, connectivity and plasticity.Hasan A et al. Curr Med Chem 2013. PMID 2315763352 Zitationen
  47. Beitrag ohne Titelangabe in PubMedErstautorFalkai P et al. Neuropsychiatr 2013. PMID 23861155

2012

  1. Muscle and timing-specific functional connectivity between the dorsolateral prefrontal cortex and the primary motor cortex.Hasan A et al. J Cogn Neurosci 2012. PMID 2324935782 Zitationen
  2. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Hasan A et al. World J Biol Psychiatry 2012. PMID 23216388312 Zitationen
  3. Post-mortem findings in mood disorders, nightmares and therapeutic approaches of psychiatric diseases.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2012. PMID 23053468
  4. The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study.ErstautorFalkai P et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2316133851 Zitationen
  5. DISC1 (disrupted-in-schizophrenia 1) is associated with cortical grey matter volumes in the human brain: a voxel-based morphometry (VBM) study.Trost S et al. J Psychiatr Res 2012. PMID 2314067216 Zitationen
  6. The future of psychosocial medicine.AlleinautorFalkai P. Nervenarzt 2012. PMID 23069893
  7. Selected issues of the DGPPN Congress in 2011.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 23053467
  8. On our own behalf: a new editorial board and focus of EAPCN.ErstautorFalkai P, Schmitt A. Eur Arch Psychiatry Clin Neurosci 2012. PMID 22955494
  9. Schizophrenia: from risk genes to outcome and comorbidity.LetztautorSchmitt A, Falkai P. Eur Arch Psychiatry Clin Neurosci 2012. PMID 229231891 Zitationen
  10. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls--a randomized placebo-controlled, double-blind fMRI study.Guse B et al. Behav Brain Res 2012. PMID 2302275057 Zitationen
  11. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.Malchow B et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2290712136 Zitationen
  12. Genome-wide association study of obsessive-compulsive disorder.Stewart SE et al. Mol Psychiatry 2012. PMID 22889921244 Zitationen
  13. Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study.Durrenberger PF et al. Acta Neuropathol 2012. PMID 2286481498 Zitationen
  14. Predictors of symptomatic remission in first-episode psychosis outpatients treated with quetiapine: a naturalistic study.Gade K et al. Int J Psychiatry Clin Pract 2012. PMID 227469873 Zitationen
  15. Biomarkers and neurobiology of schizophrenia.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2012. PMID 227437362 Zitationen
  16. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Hasan A et al. World J Biol Psychiatry 2012. PMID 22834451454 Zitationen
  17. A functional neuroimaging study assessing gender differences in the neural mechanisms underlying the ability to resist impulsive desires.Diekhof EK et al. Brain Res 2012. PMID 2281414644 Zitationen
  18. Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia.Schaeffer EL et al. J Neural Transm (Vienna) 2012. PMID 2280600413 Zitationen
  19. Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.LetztautorHabl G et al. Neuropsychobiology 2012. PMID 2279727836 Zitationen
  20. From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2012. PMID 22592946
  21. Innovative treatment approaches in schizophrenia enhancing neuroplasticity: aerobic exercise, erythropoetin and repetitive transcranial magnetic stimulation.LetztautorWobrock T et al. Curr Pharm Biotechnol 2012. PMID 2228376416 Zitationen
  22. The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.Trost S et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2258071018 Zitationen
  23. S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations.Pfennig A et al. Nervenarzt 2012. PMID 2257604928 Zitationen
  24. Regenerative psychiatry: from dementia praecox to neuronal plasticity.ErstautorFalkai P, Schmitt A. Fortschr Neurol Psychiatr 2012. PMID 22566136
  25. Future of medical psychotherapy in psychiatry.LetztautorHerpertz S, Falkai P. Psychiatr Prax 2012. PMID 225626961 Zitationen
  26. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.Hasan A et al. Biol Psychiatry 2012. PMID 2250298845 Zitationen
  27. Psychopathology: genetics and the stress-vulnerability hypothesis.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2012. PMID 224503565 Zitationen
  28. Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.Zilles D et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2245424140 Zitationen
  29. Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.Schmitt A et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2244171429 Zitationen
  30. Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.Lennertz L et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2243732144 Zitationen
  31. Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment.LetztautorWilmsdorff MV et al. World J Biol Psychiatry 2012. PMID 2242424316 Zitationen
  32. Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerations.Demiroglu SY et al. Mol Psychiatry 2012. PMID 2239203315 Zitationen
  33. Neurobiology of schizophrenia: from outcome to pathophysiological insights.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2012. PMID 222713453 Zitationen
  34. The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude - an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing.Diekhof EK et al. Neuropsychologia 2012. PMID 22366111271 Zitationen
  35. Abnormal bihemispheric responses in schizophrenia patients following cathodal transcranial direct stimulation.Hasan A et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2231833730 Zitationen
  36. Emotional status: diagnosis and treatment for severe psychiatric disorders.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2012. PMID 222031481 Zitationen
  37. Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospital.LetztautorBandelow B et al. Eur Arch Psychiatry Clin Neurosci 2012. PMID 2227473614 Zitationen

2011

  1. Sexual abuse and the consequences. This concerns all doctors.ErstautorFalkai P, Fegert JM. MMW Fortschr Med 2011. PMID 22263288
  2. Mood disorders in the light of genes, comorbidity and contemporary treatment.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2011. PMID 22045340
  3. Progress in therapy and diagnostics of neuropsychiatric diseases.AlleinautorFalkai P. Fortschr Neurol Psychiatr 2011. PMID 22048855
  4. Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study.Hasan A et al. World J Biol Psychiatry 2011. PMID 2204718334 Zitationen
  5. Personalized psychiatry and psychotherapy. Realistic hope for the future or fiction?.AlleinautorFalkai P. Nervenarzt 2011. PMID 220383843 Zitationen
  6. Response and remission in schizophrenic subjects.LetztautorZimmermann J et al. Nervenarzt 2011. PMID 212215208 Zitationen
  7. Shortage of doctors in psychiatric hospitals--providing for the future by reorganizing medical services.Jordan W et al. Psychiatr Prax 2011. PMID 220064518 Zitationen
  8. Definition of the core area of medical services in the psychiatric-psychotherapeutic field--the prerequisite for any delegation.Jordan W et al. Psychiatr Prax 2011. PMID 220064509 Zitationen
  9. Legal aspects of delegation and reorganisation of medical services in the psychiatric field.Jordan W et al. Psychiatr Prax 2011. PMID 220064495 Zitationen
  10. From generation of biomarkers to treatment and psychosocial aspects of psychosis.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2011. PMID 21927833
  11. microRNA-34c is a novel target to treat dementias.Zovoilis A et al. EMBO J 2011. PMID 21946562290 Zitationen
  12. Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study.Hasan A et al. Brain Stimul 2011. PMID 2194523175 Zitationen
  13. Impulsive personality and the ability to resist immediate reward: an fMRI study examining interindividual differences in the neural mechanisms underlying self-control.Diekhof EK et al. Hum Brain Mapp 2011. PMID 2193875648 Zitationen
  14. Reduction of gyrification index in the cerebellar vermis in schizophrenia: a post-mortem study.LetztautorSchmitt A et al. World J Biol Psychiatry 2011. PMID 2190600518 Zitationen
  15. Achievement and maintenance of the new impact factor 2010.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2011. PMID 21861244
  16. Schizophrenia as a disorder of disconnectivity.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2011. PMID 21866371177 Zitationen
  17. Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies.Delvecchio G et al. Eur Neuropsychopharmacol 2011. PMID 21820878192 Zitationen
  18. Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks.Zilles D et al. World J Biol Psychiatry 2011. PMID 217451287 Zitationen
  19. Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affect.Diekhof EK et al. Neuroimage 2011. PMID 21669291334 Zitationen
  20. Pain, affect and psychotic illness.LetztautorMöller HJ, Falkai P. Eur Arch Psychiatry Clin Neurosci 2011. PMID 21656189
  21. Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation.Hasan A et al. Behav Brain Res 2011. PMID 21645555122 Zitationen
  22. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.Wölwer W et al. Drug Alcohol Depend 2011. PMID 2162192916 Zitationen
  23. Planum temporale asymmetry to the right hemisphere in first-episode schizophrenia.Hasan A et al. Psychiatry Res 2011. PMID 2159274017 Zitationen
  24. Differential expression of HINT1 in schizophrenia brain tissue.Varadarajulu J et al. Eur Arch Psychiatry Clin Neurosci 2011. PMID 2155331126 Zitationen
  25. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.LetztautorGruber O et al. Eur Arch Psychiatry Clin Neurosci 2011. PMID 2150959541 Zitationen
  26. New lexicon and criteria for the diagnosis of Alzheimer's disease.Giaccone G et al. Lancet Neurol 2011. PMID 2143559325 Zitationen
  27. A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia.Grube S et al. EMBO Mol Med 2011. PMID 2143329061 Zitationen
  28. The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2011. PMID 21328016
  29. A desperate search for biomarkers in schizophrenia. What is going wrong?AlleinautorFalkai P. World Psychiatry 2011. PMID 213793549 Zitationen
  30. Prefrontal cortex gyrification index in twins: an MRI study.Hasan A et al. Eur Arch Psychiatry Clin Neurosci 2011. PMID 2133686722 Zitationen
  31. The psychosis continuum: diagnosis and other phenotypes.LetztautorMöller HJ, Falkai P. Eur Arch Psychiatry Clin Neurosci 2011. PMID 212435031 Zitationen
  32. The orbitofrontal cortex and its role in the assignment of behavioural significance.Diekhof EK et al. Neuropsychologia 2011. PMID 2126224225 Zitationen
  33. The role of the cerebellum in schizophrenia: from cognition to molecular pathways.Yeganeh-Doost P et al. Clinics (Sao Paulo) 2011. PMID 2177972592 Zitationen

2010

  1. Sleep, hypothalamus, and stigma.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2010. PMID 21107592
  2. Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.Schmitt A et al. World J Biol Psychiatry 2010. PMID 2109109258 Zitationen
  3. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.Brzózka MM et al. Behav Brain Res 2010. PMID 2107081422 Zitationen
  4. The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients.Ribbe K et al. BMC Psychiatry 2010. PMID 2106759845 Zitationen
  5. A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression.LetztautorGruber O et al. Eur Arch Psychiatry Clin Neurosci 2010. PMID 2106371820 Zitationen
  6. Molecular principles of tau-induced toxicity: new experimental therapy strategies for treatment of Alzheimer's disease.Schneider A et al. Nervenarzt 2010. PMID 20842339
  7. Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.Sommer JU et al. Eur Arch Psychiatry Clin Neurosci 2010. PMID 2094507022 Zitationen
  8. Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2010. PMID 20922543
  9. The speechless patient.Malchow B et al. MMW Fortschr Med 2010. PMID 20957783
  10. Tears, rage, silence: patients in state of emergency.AlleinautorFalkai P. MMW Fortschr Med 2010. PMID 20957782
  11. Understanding mental disorders from neuronal networks to glial cells and proteomics.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2010. PMID 208450224 Zitationen
  12. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.Begemann M et al. Arch Gen Psychiatry 2010. PMID 2081998174 Zitationen
  13. Guideline intentions of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN).LetztautorWobrock T et al. Nervenarzt 2010. PMID 207989168 Zitationen
  14. The power of imagination--how anticipatory mental imagery alters perceptual processing of fearful facial expressions.Diekhof EK et al. Neuroimage 2010. PMID 2079744123 Zitationen
  15. Affective disorders: the role of the duration of untreated illness, suicidality and pharmacogenetics.ErstautorFalkai P, Möller HJ. Eur Arch Psychiatry Clin Neurosci 2010. PMID 206689793 Zitationen
  16. Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls.Martins-De-Souza D et al. World J Biol Psychiatry 2010. PMID 2044688143 Zitationen
  17. Methyl- and acetyltransferases are stable epigenetic markers postmortem.Monoranu CM et al. Cell Tissue Bank 2010. PMID 2065283411 Zitationen
  18. S100B and homocysteine in the acute alcohol withdrawal syndrome.Wedekind D et al. Eur Arch Psychiatry Clin Neurosci 2010. PMID 2059319218 Zitationen
  19. Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion.Wedekind D et al. J Psychiatr Res 2010. PMID 205796628 Zitationen
  20. Search for copy number variants in chromosomes 15q11-q13 and 22q11.2 in obsessive compulsive disorder.Delorme R et al. BMC Med Genet 2010. PMID 2056592417 Zitationen
  21. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia.Wüstenberg T et al. Mol Psychiatry 2010. PMID 2047975968 Zitationen
  22. Evidence for specific cognitive deficits in visual information processing in patients with OCD compared to patients with unipolar depression.Rampacher F et al. Prog Neuropsychopharmacol Biol Psychiatry 2010. PMID 2047201328 Zitationen
  23. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.Martins-de-Souza D et al. J Psychiatr Res 2010. PMID 20471030136 Zitationen
  24. Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.Hasan A et al. J Clin Psychopharmacol 2010. PMID 2052029437 Zitationen
  25. Borderline personality disorder: a dysregulation of the endogenous opioid system?Bandelow B et al. Psychol Rev 2010. PMID 2043824099 Zitationen
  26. Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia.Martins-de-Souza D et al. J Psychiatr Res 2010. PMID 2038107065 Zitationen
  27. Early detection and treatment of schizophrenia.Hasan A et al. MMW Fortschr Med 2010. PMID 203840991 Zitationen
  28. Combination therapy in the treatment of schizophrenia.Wolff-Menzler C et al. Pharmacopsychiatry 2010. PMID 2030980924 Zitationen
  29. Correlation between amygdala volume and age in bipolar disorder - a systematic review and meta-analysis of structural MRI studies.Usher J et al. Psychiatry Res 2010. PMID 2022663853 Zitationen
  30. Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients.LetztautorParlapani E et al. World J Biol Psychiatry 2010. PMID 2021878837 Zitationen
  31. Quetiapine improves sleep disturbance in acute bipolar disorder: a case series.Cohrs S et al. Pharmacopsychiatry 2010. PMID 202050756 Zitationen
  32. What was new, interesting and frequently cited in 2009?AlleinautorFalkai P. Eur Arch Psychiatry Clin Neurosci 2010. PMID 201624262 Zitationen
  33. Proteome analysis of schizophrenia brain tissue.Martins-De-Souza D et al. World J Biol Psychiatry 2010. PMID 2010911276 Zitationen
  34. Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks.Zilles D et al. Eur Arch Psychiatry Clin Neurosci 2010. PMID 2016935424 Zitationen
  35. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?LetztautorBandelow B et al. World J Biol Psychiatry 2010. PMID 2014665115 Zitationen
  36. Thalamic volumes in patients with bipolar disorder.Radenbach K et al. Eur Arch Psychiatry Clin Neurosci 2010. PMID 2012748939 Zitationen
  37. Hippocampal plasticity in response to exercise in schizophrenia.LetztautorPajonk FG et al. Arch Gen Psychiatry 2010. PMID 20124113434 Zitationen
  38. Reduced prefrontal gyrification in obsessive-compulsive disorder.Wobrock T et al. Eur Arch Psychiatry Clin Neurosci 2010. PMID 2011202737 Zitationen
  39. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.Barakauskas VE et al. Neuropsychopharmacology 2010. PMID 2007211452 Zitationen
  40. Pathological amygdala activation during working memory performance: Evidence for a pathophysiological trait marker in bipolar affective disorder.Gruber O et al. Hum Brain Mapp 2010. PMID 1960341044 Zitationen

2009

  1. A novel mutation of the arylsulfatase A gene in late-onset metachromatic leukodystrophy.Schneider A et al. J Clin Psychiatry 2009. PMID 201417134 Zitationen
  2. Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.LetztautorWobrock T et al. Psychopharmacology (Berl) 2009. PMID 1999784431 Zitationen
  3. Quality assurance in psychiatry: quality indicators and guideline implementation.Wobrock T et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1987668228 Zitationen
  4. Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study.Cordes J et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1987667822 Zitationen
  5. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review.Guse B et al. J Neural Transm (Vienna) 2009. PMID 19859782260 Zitationen
  6. Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms.Henseler I et al. J Psychiatr Res 2009. PMID 19837416101 Zitationen
  7. Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.Habl G et al. J Neural Transm (Vienna) 2009. PMID 1982376236 Zitationen
  8. Functional interactions guiding adaptive processing of behavioral significance.Diekhof EK et al. Hum Brain Mapp 2009. PMID 1928846614 Zitationen
  9. DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis.Mössner R et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1976366233 Zitationen
  10. Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia.LetztautorParlapani E et al. Brain Res 2009. PMID 1974790129 Zitationen
  11. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.Wobrock T et al. Pharmacopsychiatry 2009. PMID 1972498236 Zitationen
  12. Perceived parental rearing in subjects with obsessive-compulsive disorder and their siblings.Lennertz L et al. Acta Psychiatr Scand 2009. PMID 1969462728 Zitationen
  13. A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia.Henseler I et al. Eur J Neurosci 2009. PMID 1968647352 Zitationen
  14. Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.Lewczuk P et al. Exp Neurol 2009. PMID 1966462293 Zitationen
  15. Increased right amygdala volume in lithium-treated patients with bipolar I disorder.Usher J et al. Acta Psychiatr Scand 2009. PMID 1957305029 Zitationen
  16. Tryptophan is a marker of human postmortem brain tissue quality.Grünblatt E et al. J Neurochem 2009. PMID 1954527912 Zitationen
  17. pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.Monoranu CM et al. Neuropathol Appl Neurobiol 2009. PMID 19473297101 Zitationen
  18. Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.Schmitt A et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1985601246 Zitationen
  19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.Goodwin G et al. Eur Neuropsychopharmacol 2009. PMID 19411165107 Zitationen
  20. Shotgun mass spectrometry analysis of the human thalamus proteome.Martins-de-Souza D et al. J Sep Sci 2009. PMID 1930132319 Zitationen
  21. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.LetztautorWobrock T et al. Acta Psychiatr Scand 2009. PMID 1939281212 Zitationen
  22. Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia.Zilles D et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1927442418 Zitationen
  23. 5-HTTLPR genotype influences amygdala volume.LetztautorScherk H et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1922411527 Zitationen
  24. Internal capsule size associated with outcome in first-episode schizophrenia.LetztautorWobrock T et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1922410827 Zitationen
  25. Comorbid substance abuse and brain morphology in recent-onset psychosis.LetztautorWobrock T et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1919464631 Zitationen
  26. From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders.LetztautorGruber O, Falkai P. Nervenarzt 2009. PMID 192127465 Zitationen
  27. Developments in diagnosis and treatment of schizophrenic psychoses.LetztautorMaier W, Falkai P. Nervenarzt 2009. PMID 19212745
  28. Effects of abstinence on brain morphology in alcoholism: a MRI study.Wobrock T et al. Eur Arch Psychiatry Clin Neurosci 2009. PMID 1916552835 Zitationen
  29. Brain mechanisms associated with background monitoring of the environment for potentially significant sensory events.Gruber O et al. Brain Cogn 2009. PMID 1913576721 Zitationen
  30. Cognition in hepatitis C patients treated with pegylated interferon.LetztautorWobrock T et al. World J Biol Psychiatry 2009. PMID 1999521911 Zitationen
  31. Cortical neurochemistry in euthymic patients with bipolar I disorder.Scherk H et al. World J Biol Psychiatry 2009. PMID 1992197017 Zitationen
  32. Early onset of obsessive-compulsive disorder and associated comorbidity.Janowitz D et al. Depress Anxiety 2009. PMID 1969102433 Zitationen
  33. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.Stober G et al. World J Biol Psychiatry 2009. PMID 1939670457 Zitationen
  34. Cognitive impairment of executive function as a core symptom of schizophrenia.Wobrock T et al. World J Biol Psychiatry 2009. PMID 1860941863 Zitationen
  35. Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen.Scherk H et al. World J Biol Psychiatry 2009. PMID 1796599412 Zitationen

2008

  1. Neurocognitive functions in euthymic bipolar patients.Jamrozinski K et al. Acta Psychiatr Scand 2008. PMID 1907611552 Zitationen
  2. Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.LetztautorSchmitt A et al. Eur Arch Psychiatry Clin Neurosci 2008. PMID 1898529218 Zitationen
  3. Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.Kessler H et al. J Neural Transm (Vienna) 2008. PMID 1897206241 Zitationen
  4. Stereologic investigation of the posterior part of the hippocampus in schizophrenia.LetztautorSchmitt A et al. Acta Neuropathol 2008. PMID 18777029133 Zitationen
  5. SNAP-25 genotype influences NAA/Cho in left hippocampus.Scherk H et al. J Neural Transm (Vienna) 2008. PMID 1872613810 Zitationen
  6. The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum.Pfuhl T et al. Neurosci Lett 2008. PMID 187081235 Zitationen
  7. Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders.Diekhof EK et al. Brain Res Rev 2008. PMID 18675846136 Zitationen
  8. The hippocampus in families with schizophrenia in relation to obstetric complications.LetztautorEbner F et al. Schizophr Res 2008. PMID 1865632931 Zitationen
  9. Behavioural alterations in rats following neonatal hypoxia and effects of clozapine: implications for schizophrenia.Fendt M et al. Pharmacopsychiatry 2008. PMID 1865134222 Zitationen
  10. Reduced cortical inhibition in first-episode schizophrenia.LetztautorWobrock T et al. Schizophr Res 2008. PMID 1862554768 Zitationen
  11. Functional brain abnormalities in psychiatric disorders: neural mechanisms to detect and resolve cognitive conflict and interference.Melcher T et al. Brain Res Rev 2008. PMID 1862107862 Zitationen
  12. Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.Kessler H et al. J Neural Transm (Vienna) 2008. PMID 1858752571 Zitationen
  13. A roadmap to disentangle the molecular etiology of schizophrenia.ErstautorFalkai P et al. Eur Psychiatry 2008. PMID 185831066 Zitationen
  14. Treatment of schizophrenia: what the family doctor should know.LetztautorGruber O, Falkai P. MMW Fortschr Med 2008. PMID 18680837
  15. Compensatory hyperactivations as markers of latent working memory dysfunctions in patients with obsessive-compulsive disorder: an fMRI study.LetztautorHenseler I et al. J Psychiatry Neurosci 2008. PMID 1859204044 Zitationen
  16. Automated gray level index measurements reveal only minor cytoarchitectonic changes of Brodmann area 9 in schizophrenia.LetztautorTepest R et al. Psychiatry Res 2008. PMID 185082456 Zitationen
  17. Limitations of current therapies: why do patients switch therapies?AlleinautorFalkai P. Eur Neuropsychopharmacol 2008. PMID 185026166 Zitationen
  18. Schizophrenia as a brain disorder and its development.ErstautorFalkai P et al. Fortschr Neurol Psychiatr 2008. PMID 184615472 Zitationen
  19. Is brain banking of psychiatric cases valuable for neurobiological research?LetztautorSchmitt A et al. Clinics (Sao Paulo) 2008. PMID 1843858117 Zitationen
  20. Development of the evidence-based S3 guideline for diagnosis and therapy of bipolar disorders.Pfennig A et al. Nervenarzt 2008. PMID 183892055 Zitationen
  21. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state.Hurlemann R et al. Psychol Med 2008. PMID 1838721359 Zitationen
  22. Gambler--porn addict--computer freak. Were is the borderline to illness?.AlleinautorFalkai P. MMW Fortschr Med 2008. PMID 18447271
  23. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.Bell JE et al. Acta Neuropathol 2008. PMID 18365220101 Zitationen
  24. No change to grey and white matter volumes in bipolar I disorder patients.Scherk H et al. Eur Arch Psychiatry Clin Neurosci 2008. PMID 1834783751 Zitationen
  25. Functional organisation of frontal cortex.LetztautorGruber O et al. Fortschr Neurol Psychiatr 2008. PMID 183116941 Zitationen
  26. Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members.Gruber O et al. J Psychiatr Res 2008. PMID 1829142035 Zitationen
  27. Structural and functional brain changes in schizophrenic disorders. Indications of early neuronal developmental disturbances?.Kalus P et al. Nervenarzt 2008. PMID 182648164 Zitationen
  28. Objective quantification of the tinnitus decompensation by synchronization measures of auditory evoked single sweeps.LetztautorStrauss DJ et al. IEEE Trans Neural Syst Rehabil Eng 2008. PMID 1830380833 Zitationen
  29. Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.Bibl M et al. Dement Geriatr Cogn Disord 2008. PMID 1827048820 Zitationen
  30. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.Scherk H et al. Acta Psychiatr Scand 2008. PMID 1820589627 Zitationen
  31. Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review.LetztautorWobrock T et al. Nervenarzt 2008. PMID 176198405 Zitationen
  32. Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder.Wedekind D et al. Curr Pharm Des 2008. PMID 190757288 Zitationen
  33. Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.Begemann M et al. Mol Med 2008. PMID 1855297621 Zitationen

2007

  1. Obsessive-compulsive disorder and posttraumatic stress disorder.Grabe HJ et al. Psychopathology 2007. PMID 1805911527 Zitationen
  2. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.Gaebel W et al. J Clin Psychiatry 2007. PMID 1805257066 Zitationen
  3. Harm avoidance in subjects with obsessive-compulsive disorder and their families.Ettelt S et al. J Affect Disord 2007. PMID 1785490856 Zitationen
  4. Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation.LetztautorWobrock T et al. Nervenarzt 2007. PMID 171198884 Zitationen
  5. Reduction of the internal capsule in families affected with schizophrenia.LetztautorWobrock T et al. Biol Psychiatry 2007. PMID 1757421534 Zitationen
  6. Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives.Schneider F et al. Psychiatry Res 2007. PMID 1753219354 Zitationen
  7. Health-related quality of life in hereditary hemorrhagic telangiectasia.Geisthoff UW et al. Otolaryngol Head Neck Surg 2007. PMID 1747820582 Zitationen
  8. Clinical standing of valproate treatment of bipolar disorders.Grunze H et al. Fortschr Neurol Psychiatr 2007. PMID 17427043
  9. Altered cholesterol metabolism in APP695-transfected neuroblastoma cells.Wirths O et al. Brain Res 2007. PMID 174284495 Zitationen
  10. Dynamic interactions between neural systems underlying different components of verbal working memory.LetztautorGruber O et al. J Neural Transm (Vienna) 2007. PMID 1731830114 Zitationen
  11. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.Bertram I et al. Ann N Y Acad Sci 2007. PMID 1740592686 Zitationen
  12. Impulsiveness in obsessive-compulsive disorder: results from a family study.Ettelt S et al. Acta Psychiatr Scand 2007. PMID 1720186551 Zitationen

2006

  1. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.Schmitt A et al. J Neural Transm (Vienna) 2006. PMID 1716510137 Zitationen
  2. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.Wobrock T et al. Eur Arch Psychiatry Clin Neurosci 2006. PMID 1713121434 Zitationen
  3. Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects.Grabe HJ et al. Am J Psychiatry 2006. PMID 1707495167 Zitationen
  4. Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts.ErstautorFalkai P, Maier W. Nervenarzt 2006. PMID 170725674 Zitationen
  5. Disturbed frontal gyrification within families affected with schizophrenia.ErstautorFalkai P et al. J Psychiatr Res 2006. PMID 1707084654 Zitationen
  6. Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia.Schmitt A et al. J Neural Transm (Vienna) 2006. PMID 1705387421 Zitationen
  7. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.Ehrenreich H et al. Mol Psychiatry 2006. PMID 17033631208 Zitationen
  8. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).LetztautorRösler M et al. Eur Arch Psychiatry Clin Neurosci 2006. PMID 1697754987 Zitationen
  9. Pharmacological treatment options in frontotemporal dementia.LetztautorKessler H et al. Fortschr Neurol Psychiatr 2006. PMID 169722106 Zitationen
  10. Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder.LetztautorGruber O et al. Neurosci Lett 2006. PMID 1687578142 Zitationen
  11. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.Jessen F et al. Schizophr Res 2006. PMID 1684297157 Zitationen
  12. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.Kessler H et al. J Neural Transm (Vienna) 2006. PMID 1673624265 Zitationen
  13. Cholesterol synthesis rate in human hippocampus declines with aging.Thelen KM et al. Neurosci Lett 2006. PMID 1670194684 Zitationen
  14. Cognitive changes after carotid artery stenting.Grunwald IQ et al. Neuroradiology 2006. PMID 1670336151 Zitationen
  15. Effects of antipsychotics on brain structure.LetztautorScherk H, Falkai P. Curr Opin Psychiatry 2006. PMID 16612194168 Zitationen
  16. Neural mechanisms of advance preparation in task switching.Gruber O et al. Neuroimage 2006. PMID 1649036538 Zitationen
  17. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.Honer WG et al. N Engl J Med 2006. PMID 16452559189 Zitationen
  18. Large-scale inverse and forward modeling of adaptive resonance in the tinnitus decompensation.Low YF et al. Conf Proc IEEE Eng Med Biol Soc 2006. PMID 179469673 Zitationen
  19. Alexithymia in obsessive-compulsive disorder - results from a family study.Grabe HJ et al. Psychother Psychosom 2006. PMID 1689996836 Zitationen
  20. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.ErstautorFalkai P et al. World J Biol Psychiatry 2006. PMID 16509050107 Zitationen

2005

  1. Intact hippocampal gray matter in schizophrenia as revealed by automatized image analysis postmortem.Hurlemann R et al. Anat Embryol (Berl) 2005. PMID 1618713910 Zitationen
  2. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.Hurlemann R et al. Anat Embryol (Berl) 2005. PMID 1618713831 Zitationen
  3. Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease.Wirths O et al. Exp Gerontol 2005. PMID 1630785817 Zitationen
  4. Reductions in cholesterol and synaptic markers in association cortex in mood disorders.Beasley CL et al. Bipolar Disord 2005. PMID 16176438102 Zitationen
  5. Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease.Pajonk FG et al. J Alzheimers Dis 2005. PMID 1615534666 Zitationen
  6. Relation between cerebrospinal fluid, gray matter and white matter changes in families with schizophrenia.LetztautorSchneider-Axmann T et al. J Psychiatr Res 2005. PMID 160190308 Zitationen
  7. Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication.LetztautorSchmitt A et al. Neuropsychiatr Dis Treat 2005. PMID 1856806360 Zitationen
  8. Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms.LetztautorSchmitt A et al. Schizophr Res 2005. PMID 1596474264 Zitationen
  9. Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.Szczygielski J et al. J Neural Transm (Vienna) 2005. PMID 1595983853 Zitationen
  10. The role of copper in the pathophysiology of Alzheimer's disease.Kessler H et al. Nervenarzt 2005. PMID 1590598312 Zitationen
  11. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression.Schulze-Rauschenbach SC et al. Br J Psychiatry 2005. PMID 1586374683 Zitationen
  12. Longterm therapy of schizophrenia.LetztautorPajonk FG et al. Fortschr Neurol Psychiatr 2005. PMID 15806439
  13. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.Sawada K et al. Arch Gen Psychiatry 2005. PMID 1575323989 Zitationen
  14. Longterm therapy of schizophrenia.LetztautorPajonk FG et al. Fortschr Neurol Psychiatr 2005. PMID 157472261 Zitationen
  15. Neural correlates of working memory deficits in schizophrenic patients. Ways to establish neurocognitive endophenotypes of psychiatric disorders.LetztautorGruber O et al. Radiologe 2005. PMID 1564520421 Zitationen
  16. Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations.LetztautorWobrock T et al. Radiologe 2005. PMID 156452038 Zitationen
  17. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.ErstautorFalkai P et al. World J Biol Psychiatry 2005. PMID 16173147222 Zitationen

2004

  1. Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view.ErstautorFalkai P et al. Psychiatry Res 2004. PMID 156647975 Zitationen
  2. Acute treatment of schizophrenia.Wobrock T et al. Fortschr Neurol Psychiatr 2004. PMID 155805354 Zitationen
  3. Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.Schmaljohann J et al. Appl Radiat Isot 2004. PMID 1538811528 Zitationen
  4. Etiopathogenetic mechanisms in long-term course of schizophrenia.ErstautorFalkai P et al. Pharmacopsychiatry 2004. PMID 155460656 Zitationen
  5. Changes in brain structure caused by neuroleptic medication.LetztautorScherk H, Falkai P. Nervenarzt 2004. PMID 153656327 Zitationen
  6. Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients.Habel U et al. Am J Psychiatry 2004. PMID 1546597790 Zitationen
  7. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF.Rothermundt M et al. Mol Psychiatry 2004. PMID 15241436116 Zitationen
  8. MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls.Supprian T et al. Psychiatry Res 2004. PMID 1546529623 Zitationen
  9. Changes in brain structure in bipolar affective disorders.LetztautorScherk H et al. Nervenarzt 2004. PMID 151188245 Zitationen
  10. Psychological distress associated with acute tinnitus.D'Amelio R et al. HNO 2004. PMID 1530925642 Zitationen
  11. Neural correlates of first-person perspective as one constituent of human self-consciousness.Vogeley K et al. J Cogn Neurosci 2004. PMID 15200709356 Zitationen
  12. Schizophrenia.LetztautorWobrock T et al. Fortschr Neurol Psychiatr 2004. PMID 149995962 Zitationen
  13. Schizophrenia.LetztautorWobrock T et al. Fortschr Neurol Psychiatr 2004. PMID 147703504 Zitationen
  14. Erythropoietin: a candidate compound for neuroprotection in schizophrenia.Ehrenreich H et al. Mol Psychiatry 2004. PMID 14581931155 Zitationen

2003

  1. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.Kühn KU et al. Epilepsy Behav 2003. PMID 1469870188 Zitationen
  2. Hippocampal deformities in the unaffected siblings of schizophrenia subjects.Tepest R et al. Biol Psychiatry 2003. PMID 1464309159 Zitationen
  3. Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis.LetztautorKovalenko S et al. Pharmacopsychiatry 2003. PMID 1467707320 Zitationen
  4. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins.Flynn SW et al. Mol Psychiatry 2003. PMID 12931208363 Zitationen
  5. The importance of interneurons in schizophrenic and affective disorders.LetztautorScherk H et al. Fortschr Neurol Psychiatr 2003. PMID 129475402 Zitationen
  6. Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia.LetztautorVogeley K et al. Schizophr Res 2003. PMID 1276575328 Zitationen
  7. White matter alterations in neurodegenerative and vascular dementia.LetztautorSupprian T et al. Radiologe 2003. PMID 129552173 Zitationen
  8. Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: a MRI study.ErstautorFalkai P et al. Eur Arch Psychiatry Clin Neurosci 2003. PMID 1279974826 Zitationen
  9. Developmental abnormalities of the hippocampus in first-episode schizophrenia.Smith GN et al. Biol Psychiatry 2003. PMID 1267923243 Zitationen
  10. Volumes of association thalamic nuclei in schizophrenia: a postmortem study.Danos P et al. Schizophr Res 2003. PMID 12591578113 Zitationen
  11. Homocysteine and dementia.Kessler H et al. Fortschr Neurol Psychiatr 2003. PMID 1262485217 Zitationen
  12. DGPPN policy paper on quality assurance and guidelines. Current status and perspectives of guideline development.LetztautorGaebel W, Falkai P. Nervenarzt 2003. PMID 126854472 Zitationen
  13. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus.Seidman LJ et al. Schizophr Bull 2003. PMID 14989416115 Zitationen
  14. Volumetric analysis of gray matter, white matter and cerebrospinal fluid space in schizophrenia.LetztautorMarić N et al. Srp Arh Celok Lek 2003. PMID 146088583 Zitationen
  15. Trait characteristic of impaired visuomotor integration during Trail-Making Test B performance in schizophrenia.Wölwer W et al. Neuropsychobiology 2003. PMID 1450441214 Zitationen
  16. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.Bender S et al. Pharmacopsychiatry 2003. PMID 1273476313 Zitationen

2002

  1. Cardiac risk of psychotropic drugs.Ames D et al. Aust N Z J Psychiatry 2002. PMID 124061323 Zitationen
  2. The dichotomy of schizophrenia and affective disorders in extended pedigrees.Maier W et al. Schizophr Res 2002. PMID 1222325757 Zitationen
  3. The temporal lobe in schizophrenia from uni- and multiply affected families.ErstautorFalkai P et al. Neurosci Lett 2002. PMID 1202305914 Zitationen
  4. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.Honer WG et al. Cereb Cortex 2002. PMID 11884350104 Zitationen
  5. The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study.Danos P et al. Psychiatry Res 2002. PMID 1186480545 Zitationen
  6. Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group.Ames D et al. Encephale 2002. PMID 1250626820 Zitationen
  7. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.Sawada K et al. Mol Psychiatry 2002. PMID 1208256680 Zitationen

2001

  1. Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia.Jessen F et al. Neurosci Lett 2001. PMID 1151407283 Zitationen
  2. Mind reading: neural mechanisms of theory of mind and self-perspective.Vogeley K et al. Neuroimage 2001. PMID 11525326624 Zitationen
  3. Public press commitment of the DGPPN (German Society of Psychiatry, Psychotherapy and Neurology.ErstautorFalkai P, Schmauss M. Nervenarzt 2001. PMID 11386152
  4. Structural brain changes in patients with schizophrenic psychoses. From focal pathology to network disorder.ErstautorFalkai P et al. Nervenarzt 2001. PMID 1138614310 Zitationen
  5. Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: a morphometric mri study.LetztautorVogeley K et al. Am J Psychiatry 2001. PMID 1122999884 Zitationen
  6. Prevalence and clinical significance of computerized tomography verified idiopathic calcinosis of the basal ganglia.Gomille T et al. Radiologe 2001. PMID 1125310823 Zitationen

2000

  1. Vagus nerve stimulation is associated with mood improvements in epilepsy patients.Elger G et al. Epilepsy Res 2000. PMID 11074193231 Zitationen
  2. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6.Schwab SG et al. Mol Psychiatry 2000. PMID 11126394132 Zitationen
  3. Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study.LetztautorKawasak Y et al. Prog Neuropsychopharmacol Biol Psychiatry 2000. PMID 1113117415 Zitationen
  4. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder.LetztautorBayer TA et al. Prog Neuropsychopharmacol Biol Psychiatry 2000. PMID 1104153131 Zitationen
  5. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.LetztautorBlock W et al. Neurosci Lett 2000. PMID 1090414155 Zitationen
  6. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality.ErstautorFalkai P et al. Biol Psychiatry 2000. PMID 1083806182 Zitationen
  7. The chances of new atypical substances.ErstautorFalkai P, Vogeley K. Fortschr Neurol Psychiatr 2000. PMID 109076114 Zitationen
  8. Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study.LetztautorVogeley K et al. Am J Psychiatry 2000. PMID 10618010104 Zitationen

1999

  1. Differential memory span--abnormal lateralization pattern in schizophrenic patients and their siblings?Franke P et al. Int J Psychophysiol 1999. PMID 1061005411 Zitationen
  2. Genetics of schizophrenic disorders. New concepts and findings.Maier W et al. Nervenarzt 1999. PMID 106035895 Zitationen
  3. Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders.Czygan M et al. J Infect Dis 1999. PMID 1051583528 Zitationen
  4. Neural expression profile of alpha-synuclein in developing human cortex.Bayer TA et al. Neuroreport 1999. PMID 1051144354 Zitationen
  5. Essential functions of the human self model are implemented in the prefrontal cortex.Vogeley K et al. Conscious Cogn 1999. PMID 1048778852 Zitationen
  6. Evidence for activation of microglia in patients with psychiatric illnesses.LetztautorBayer TA et al. Neurosci Lett 1999. PMID 10477118257 Zitationen
  7. Cortical sulcal enlargement in catatonic schizophrenia: a planimetric CT study.Northoff G et al. Psychiatry Res 1999. PMID 1049669124 Zitationen
  8. The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases.LetztautorMaier W, Falkai P. Int Clin Psychopharmacol 1999. PMID 1047116653 Zitationen
  9. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.Bayer TA et al. Neurosci Lett 1999. PMID 1046571178 Zitationen
  10. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.ErstautorFalkai P et al. Neuropathol Appl Neurobiol 1999. PMID 1019477590 Zitationen
  11. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis".Bayer TA et al. J Psychiatr Res 1999. PMID 10628531234 Zitationen
  12. Mirtazapine: other indications.AlleinautorFalkai P. J Clin Psychiatry 1999. PMID 1044674126 Zitationen
  13. Stability of RNA transcripts in post-mortem psychiatric brains.Schramm M et al. J Neural Transm (Vienna) 1999. PMID 1039254157 Zitationen
  14. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness.Honer WG et al. Neuroscience 1999. PMID 10391432165 Zitationen
  15. Neural expression profile of Elav-like genes in human brain.Schramm M et al. Clin Neuropathol 1999. PMID 99881343 Zitationen

1998

  1. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia.Schramm M et al. Neurosci Lett 1998. PMID 986592831 Zitationen
  2. Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia.Bernstein HG et al. Schizophr Res 1998. PMID 978990455 Zitationen
  3. Projecting the sulcal pattern of human brains onto a 2D plane--a new approach using potential theory and MRI.Haidekker MA et al. Psychiatry Res 1998. PMID 98187334 Zitationen
  4. Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia--a post-mortem study.LetztautorVogeley K et al. Schizophr Res 1998. PMID 968971220 Zitationen
  5. Obstetric complications, treatment response and brain morphology in adult-onset and early-onset males with schizophrenia.Smith GN et al. Psychol Med 1998. PMID 962672015 Zitationen
  6. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.Danos P et al. Psychiatry Res 1998. PMID 9645546126 Zitationen
  7. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics.Bernstein HG et al. Neuroscience 1998. PMID 9483570191 Zitationen
  8. Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia.Przkora R et al. Eur Arch Psychiatry Clin Neurosci 1998. PMID 9928911
  9. SNAP-25 deficit and hippocampal connectivity in schizophrenia.Young CE et al. Cereb Cortex 1998. PMID 9617921137 Zitationen

1997

  1. A comprehensive method of assessing routine CT scans in schizophrenia.Smith GN et al. Acta Psychiatr Scand 1997. PMID 93951599 Zitationen
  2. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex.Harrison PJ et al. Schizophr Res 1997. PMID 932333819 Zitationen
  3. Graduate and continuing education seminars in psychiatry and psychotherapy.Schneider F et al. Nervenarzt 1997. PMID 9280858
  4. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.Honer WG et al. Neuroscience 1997. PMID 9135092129 Zitationen
  5. Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type.Heun R et al. Dement Geriatr Cogn Disord 1997. PMID 937008452 Zitationen

1996

  1. Differential diagnosis in acute psychotic episode.AlleinautorFalkai P. Int Clin Psychopharmacol 1996. PMID 880365520 Zitationen
  2. Practice guidelines in psychiatry. Methodology and status of guideline development.LetztautorGaebel W, Falkai P. Nervenarzt 1996. PMID 88513021 Zitationen
  3. Proceedings of the German Society of Psychiatry, Psychotherapy and Neurology.LetztautorGaebel W, Falkai P. Nervenarzt 1996. PMID 8676995
  4. A case study of temporal lobe development in familial schizophrenia.Honer WG et al. Psychol Med 1996. PMID 864375818 Zitationen
  5. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction.Taller AM et al. Arch Gen Psychiatry 1996. PMID 854077532 Zitationen

1995

  1. The temporal lobes, reversed asymmetry and the genetics of schizophrenia.Honer WG et al. Neuroreport 1995. PMID 874245618 Zitationen
  2. Brain morphology assessed by computed tomography in patients with geriatric depression, patients with degenerative dementia, and normal control subjects.LetztautorWurthmann C et al. Psychiatry Res 1995. PMID 748038722 Zitationen
  3. Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study.ErstautorFalkai P et al. Schizophr Res 1995. PMID 7710997127 Zitationen
  4. Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance.ErstautorFalkai P et al. J Neural Transm Gen Sect 1995. PMID 857980844 Zitationen

1994

  1. Temporal lobe abnormalities in multigenerational families with schizophrenia.LetztautorHoner WG et al. Biol Psychiatry 1994. PMID 785806930 Zitationen
  2. In vivo morphometry of planum temporale asymmetry in first-episode schizophrenia.Kleinschmidt A et al. Schizophr Res 1994. PMID 801858960 Zitationen
  3. The distribution of nitric oxide synthase immunoreactivity in the human brain.Egberongbe YI et al. Neuroscience 1994. PMID 7516503169 Zitationen

1993

  1. The neuropathology of schizophrenia: past and present.Bogerts B et al. J Hirnforsch 1993. PMID 822818121 Zitationen

1992

  1. Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients.Degreef G et al. Psychiatry Res 1992. PMID 141007494 Zitationen
  2. Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study.ErstautorFalkai P et al. Schizophr Res 1992. PMID 1591194124 Zitationen
  3. Neurodevelopmental abnormalities in schizophrenia.ErstautorFalkai P, Bogerts B. Clin Neuropharmacol 1992. PMID 14989275 Zitationen

1991

  1. Evidence of reduced temporolimbic structure volumes in schizophrenia.Bogerts B et al. Arch Gen Psychiatry 1991. PMID 192976718 Zitationen

1990

  1. Nasopharyngeally and vertex recorded P300's in normal subjects.Schellenberg R et al. Int J Psychophysiol 1990. PMID 22287555 Zitationen
  2. Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection.Bogerts B et al. Schizophr Res 1990. PMID 2282334187 Zitationen

1989

  1. Distribution of galanin-like immunoreactivity in the human brain.Gentleman SM et al. Brain Res 1989. PMID 248083691 Zitationen
  2. Visual hallucinations in the elderly associated with the use of levodopa.Banerjee AK et al. Postgrad Med J 1989. PMID 269201226 Zitationen

1988

  1. Quantitative study of gliosis in schizophrenia and Huntington's chorea.LetztautorStevens CD et al. Biol Psychiatry 1988. PMID 297140254 Zitationen
  2. Limbic pathology in schizophrenia: the entorhinal region--a morphometric study.ErstautorFalkai P et al. Biol Psychiatry 1988. PMID 3167140342 Zitationen

1986

  1. Cell loss in the hippocampus of schizophrenics.ErstautorFalkai P, Bogerts B. Eur Arch Psychiatry Neurol Sci 1986. PMID 3803399372 Zitationen

Quelle: PubMed, Suche Falkai P[Author]. Konsortialarbeiten, in denen er nur als Mitglied einer Studiengruppe geführt wird, sind nicht enthalten. Zitationen aus NIH iCite zählen nur Zitate aus PubMed-Literatur; Google Scholar zeigt höhere Werte.